| ENSG00000177406.4 |
Nilotinib |
Bladder urothelial carcinoma |
0.048445299 |
Resistant |
| ENSG00000198221.7 |
Nilotinib |
Bladder urothelial carcinoma |
0.042315925 |
Resistant |
| ENSG00000206195.6 |
Nilotinib |
Bladder urothelial carcinoma |
0.049250151 |
Resistant |
| ENSG00000215241.3 |
Nilotinib |
Bladder urothelial carcinoma |
0.010579655 |
Resistant |
| ENSG00000228115.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.010526449 |
Resistant |
| ENSG00000234694.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.0151656 |
Resistant |
| ENSG00000241155.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.044012637 |
Resistant |
| ENSG00000244306.5 |
Nilotinib |
Bladder urothelial carcinoma |
0.024537773 |
Resistant |
| ENSG00000256596.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.029630261 |
Resistant |
| ENSG00000260988.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.003567822 |
Resistant |
| ENSG00000261189.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.047583481 |
Resistant |
| ENSG00000262873.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.026301033 |
Resistant |
| ENSG00000267128.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.021721167 |
Resistant |
| ENSG00000271127.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.035804047 |
Resistant |
| ENSG00000272024.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.014534996 |
Resistant |
| ENSG00000272088.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.034461631 |
Resistant |
| ENSG00000272403.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.039278254 |
Resistant |
| ENSG00000178412.4 |
Nilotinib |
Breast invasive carcinoma |
0.021219083 |
Resistant |
| ENSG00000178803.6 |
Nilotinib |
Breast invasive carcinoma |
0.021564665 |
Resistant |
| ENSG00000182165.13 |
Nilotinib |
Breast invasive carcinoma |
0.020752565 |
Resistant |
| ENSG00000203496.4 |
Nilotinib |
Breast invasive carcinoma |
0.023830789 |
Resistant |
| ENSG00000217576.7 |
Nilotinib |
Breast invasive carcinoma |
0.025312851 |
Resistant |
| ENSG00000226690.2 |
Nilotinib |
Breast invasive carcinoma |
0.003098706 |
Resistant |
| ENSG00000227409.1 |
Nilotinib |
Breast invasive carcinoma |
0.032597176 |
Resistant |
| ENSG00000227603.1 |
Nilotinib |
Breast invasive carcinoma |
0.008008109 |
Resistant |
| ENSG00000228906.1 |
Nilotinib |
Breast invasive carcinoma |
0.015509691 |
Resistant |
| ENSG00000229807.5 |
Nilotinib |
Breast invasive carcinoma |
0.034253241 |
Resistant |
| ENSG00000230292.1 |
Nilotinib |
Breast invasive carcinoma |
0.043413689 |
Resistant |
| ENSG00000230368.2 |
Nilotinib |
Breast invasive carcinoma |
0.000415116 |
Resistant |
| ENSG00000230433.1 |
Nilotinib |
Breast invasive carcinoma |
0.031210661 |
Resistant |
| ENSG00000230736.2 |
Nilotinib |
Breast invasive carcinoma |
0.002070343 |
Resistant |
| ENSG00000230881.1 |
Nilotinib |
Breast invasive carcinoma |
0.000502824 |
Resistant |
| ENSG00000230899.1 |
Nilotinib |
Breast invasive carcinoma |
0.036122791 |
Resistant |
| ENSG00000231025.1 |
Nilotinib |
Breast invasive carcinoma |
0.001872074 |
Resistant |
| ENSG00000231519.1 |
Nilotinib |
Breast invasive carcinoma |
0.024301022 |
Resistant |
| ENSG00000231948.2 |
Nilotinib |
Breast invasive carcinoma |
0.045541972 |
Resistant |
| ENSG00000232124.1 |
Nilotinib |
Breast invasive carcinoma |
0.019085787 |
Resistant |
| ENSG00000233008.1 |
Nilotinib |
Breast invasive carcinoma |
0.0065393 |
Resistant |
| ENSG00000233895.1 |
Nilotinib |
Breast invasive carcinoma |
0.044898844 |
Resistant |
| ENSG00000234050.1 |
Nilotinib |
Breast invasive carcinoma |
0.035895522 |
Resistant |
| ENSG00000234185.2 |
Nilotinib |
Breast invasive carcinoma |
0.045569523 |
Resistant |
| ENSG00000234617.1 |
Nilotinib |
Breast invasive carcinoma |
0.031546912 |
Resistant |
| ENSG00000235958.1 |
Nilotinib |
Breast invasive carcinoma |
0.025795563 |
Resistant |
| ENSG00000236008.1 |
Nilotinib |
Breast invasive carcinoma |
0.049124639 |
Resistant |
| ENSG00000236535.1 |
Nilotinib |
Breast invasive carcinoma |
0.046567493 |
Resistant |
| ENSG00000237614.1 |
Nilotinib |
Breast invasive carcinoma |
0.048439676 |
Resistant |
| ENSG00000240499.3 |
Nilotinib |
Breast invasive carcinoma |
0.027399541 |
Resistant |
| ENSG00000241163.3 |
Nilotinib |
Breast invasive carcinoma |
0.04078436 |
Resistant |
| ENSG00000241954.1 |
Nilotinib |
Breast invasive carcinoma |
0.002906284 |
Resistant |
| ENSG00000244063.1 |
Nilotinib |
Breast invasive carcinoma |
0.031909159 |
Resistant |
| ENSG00000245148.2 |
Nilotinib |
Breast invasive carcinoma |
0.039586647 |
Resistant |
| ENSG00000245729.1 |
Nilotinib |
Breast invasive carcinoma |
0.025419543 |
Resistant |
| ENSG00000247516.3 |
Nilotinib |
Breast invasive carcinoma |
0.039945127 |
Resistant |
| ENSG00000247982.2 |
Nilotinib |
Breast invasive carcinoma |
0.016687492 |
Resistant |
| ENSG00000249159.2 |
Nilotinib |
Breast invasive carcinoma |
0.032824356 |
Resistant |
| ENSG00000251615.3 |
Nilotinib |
Breast invasive carcinoma |
0.036421534 |
Resistant |
| ENSG00000254664.1 |
Nilotinib |
Breast invasive carcinoma |
0.019273914 |
Resistant |
| ENSG00000254988.1 |
Nilotinib |
Breast invasive carcinoma |
0.039809476 |
Resistant |
| ENSG00000256006.1 |
Nilotinib |
Breast invasive carcinoma |
0.047192063 |
Resistant |
| ENSG00000257176.1 |
Nilotinib |
Breast invasive carcinoma |
0.013755228 |
Resistant |
| ENSG00000257474.1 |
Nilotinib |
Breast invasive carcinoma |
0.004725267 |
Resistant |
| ENSG00000257568.1 |
Nilotinib |
Breast invasive carcinoma |
0.006267152 |
Resistant |
| ENSG00000258891.1 |
Nilotinib |
Breast invasive carcinoma |
0.015878173 |
Resistant |
| ENSG00000259206.1 |
Nilotinib |
Breast invasive carcinoma |
0.007789289 |
Resistant |
| ENSG00000259417.2 |
Nilotinib |
Breast invasive carcinoma |
0.042064798 |
Resistant |
| ENSG00000260176.1 |
Nilotinib |
Breast invasive carcinoma |
0.018509791 |
Resistant |
| ENSG00000260349.1 |
Nilotinib |
Breast invasive carcinoma |
0.013091479 |
Resistant |
| ENSG00000260404.2 |
Nilotinib |
Breast invasive carcinoma |
0.019404608 |
Resistant |
| ENSG00000260417.1 |
Nilotinib |
Breast invasive carcinoma |
0.043696478 |
Resistant |
| ENSG00000260470.1 |
Nilotinib |
Breast invasive carcinoma |
0.048140346 |
Resistant |
| ENSG00000260579.1 |
Nilotinib |
Breast invasive carcinoma |
0.034488457 |
Resistant |
| ENSG00000260672.1 |
Nilotinib |
Breast invasive carcinoma |
0.002766089 |
Resistant |
| ENSG00000260698.1 |
Nilotinib |
Breast invasive carcinoma |
0.016170645 |
Resistant |
| ENSG00000260814.2 |
Nilotinib |
Breast invasive carcinoma |
0.01531634 |
Resistant |
| ENSG00000261096.1 |
Nilotinib |
Breast invasive carcinoma |
0.043032203 |
Resistant |
| ENSG00000261186.1 |
Nilotinib |
Breast invasive carcinoma |
0.019692636 |
Resistant |
| ENSG00000261288.1 |
Nilotinib |
Breast invasive carcinoma |
0.018734276 |
Resistant |
| ENSG00000261496.1 |
Nilotinib |
Breast invasive carcinoma |
0.028571965 |
Resistant |
| ENSG00000261505.1 |
Nilotinib |
Breast invasive carcinoma |
0.045803011 |
Resistant |
| ENSG00000261578.1 |
Nilotinib |
Breast invasive carcinoma |
0.018107511 |
Resistant |
| ENSG00000261613.2 |
Nilotinib |
Breast invasive carcinoma |
0.026242526 |
Resistant |
| ENSG00000262944.1 |
Nilotinib |
Breast invasive carcinoma |
0.006716866 |
Resistant |
| ENSG00000262979.1 |
Nilotinib |
Breast invasive carcinoma |
0.026669433 |
Resistant |
| ENSG00000265845.2 |
Nilotinib |
Breast invasive carcinoma |
0.014133331 |
Resistant |
| ENSG00000267163.1 |
Nilotinib |
Breast invasive carcinoma |
0.048807867 |
Resistant |
| ENSG00000267222.1 |
Nilotinib |
Breast invasive carcinoma |
0.036801299 |
Resistant |
| ENSG00000267532.2 |
Nilotinib |
Breast invasive carcinoma |
0.019344726 |
Resistant |
| ENSG00000268095.1 |
Nilotinib |
Breast invasive carcinoma |
0.022115502 |
Resistant |
| ENSG00000270018.1 |
Nilotinib |
Breast invasive carcinoma |
0.033036629 |
Resistant |
| ENSG00000270048.1 |
Nilotinib |
Breast invasive carcinoma |
0.02317487 |
Resistant |
| ENSG00000270067.1 |
Nilotinib |
Breast invasive carcinoma |
0.025559238 |
Resistant |
| ENSG00000270104.1 |
Nilotinib |
Breast invasive carcinoma |
0.027959034 |
Resistant |
| ENSG00000270109.1 |
Nilotinib |
Breast invasive carcinoma |
0.01980531 |
Resistant |
| ENSG00000270124.1 |
Nilotinib |
Breast invasive carcinoma |
0.004639095 |
Resistant |
| ENSG00000270174.1 |
Nilotinib |
Breast invasive carcinoma |
0.032399017 |
Resistant |
| ENSG00000270223.1 |
Nilotinib |
Breast invasive carcinoma |
0.007066736 |
Resistant |
| ENSG00000270462.1 |
Nilotinib |
Breast invasive carcinoma |
0.027366674 |
Resistant |
| ENSG00000270641.1 |
Nilotinib |
Breast invasive carcinoma |
0.034405437 |
Resistant |
| ENSG00000271327.1 |
Nilotinib |
Breast invasive carcinoma |
0.005067373 |
Resistant |
| ENSG00000271911.1 |
Nilotinib |
Breast invasive carcinoma |
0.014928307 |
Resistant |
| ENSG00000272005.1 |
Nilotinib |
Breast invasive carcinoma |
0.014948622 |
Resistant |
| ENSG00000272144.1 |
Nilotinib |
Breast invasive carcinoma |
0.022855938 |
Resistant |
| ENSG00000272485.1 |
Nilotinib |
Breast invasive carcinoma |
0.009456968 |
Resistant |
| ENSG00000272508.1 |
Nilotinib |
Breast invasive carcinoma |
0.032520386 |
Resistant |
| ENSG00000272734.1 |
Nilotinib |
Breast invasive carcinoma |
0.041494972 |
Resistant |
| ENSG00000272940.1 |
Nilotinib |
Breast invasive carcinoma |
0.04871078 |
Resistant |
| ENSG00000273059.1 |
Nilotinib |
Breast invasive carcinoma |
0.026055914 |
Resistant |
| ENSG00000273402.1 |
Nilotinib |
Breast invasive carcinoma |
0.046644294 |
Resistant |
| ENSG00000203362.2 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029233212 |
Resistant |
| ENSG00000203875.6 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009558593 |
Resistant |
| ENSG00000227484.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034017999 |
Resistant |
| ENSG00000229227.4 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03047945 |
Resistant |
| ENSG00000230337.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046117404 |
Resistant |
| ENSG00000231104.4 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019650656 |
Resistant |
| ENSG00000231329.3 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03984522 |
Resistant |
| ENSG00000231563.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045085733 |
Resistant |
| ENSG00000231728.2 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015440316 |
Resistant |
| ENSG00000232377.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034145375 |
Resistant |
| ENSG00000232907.3 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024916629 |
Resistant |
| ENSG00000233330.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006613831 |
Resistant |
| ENSG00000233461.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043424746 |
Resistant |
| ENSG00000233613.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044664426 |
Resistant |
| ENSG00000233785.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048594644 |
Resistant |
| ENSG00000233847.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034376021 |
Resistant |
| ENSG00000234327.3 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014321518 |
Resistant |
| ENSG00000234630.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019690399 |
Resistant |
| ENSG00000234793.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049354897 |
Resistant |
| ENSG00000236305.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04779612 |
Resistant |
| ENSG00000236850.4 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022390185 |
Resistant |
| ENSG00000236943.2 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039380487 |
Resistant |
| ENSG00000237188.3 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035693539 |
Resistant |
| ENSG00000237502.2 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004608435 |
Resistant |
| ENSG00000237805.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028172526 |
Resistant |
| ENSG00000240758.2 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035857601 |
Resistant |
| ENSG00000243701.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040192918 |
Resistant |
| ENSG00000245060.2 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035814419 |
Resistant |
| ENSG00000247095.2 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020425428 |
Resistant |
| ENSG00000248367.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041256923 |
Resistant |
| ENSG00000249684.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020765885 |
Resistant |
| ENSG00000250909.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038520762 |
Resistant |
| ENSG00000257696.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034227683 |
Resistant |
| ENSG00000257824.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04463855 |
Resistant |
| ENSG00000258044.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020362479 |
Resistant |
| ENSG00000258136.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02023867 |
Resistant |
| ENSG00000258450.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044730465 |
Resistant |
| ENSG00000259153.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047229138 |
Resistant |
| ENSG00000259469.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029191668 |
Resistant |
| ENSG00000259595.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03192064 |
Resistant |
| ENSG00000259921.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022071962 |
Resistant |
| ENSG00000260038.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041690672 |
Resistant |
| ENSG00000260447.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034019308 |
Resistant |
| ENSG00000260743.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04710216 |
Resistant |
| ENSG00000260917.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030587191 |
Resistant |
| ENSG00000260920.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01210395 |
Resistant |
| ENSG00000261015.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012136749 |
Resistant |
| ENSG00000261124.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029871583 |
Resistant |
| ENSG00000261251.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006717187 |
Resistant |
| ENSG00000261416.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0439513 |
Resistant |
| ENSG00000262222.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037384117 |
Resistant |
| ENSG00000263013.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040840301 |
Resistant |
| ENSG00000263916.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023052416 |
Resistant |
| ENSG00000267011.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039508502 |
Resistant |
| ENSG00000267751.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039683849 |
Resistant |
| ENSG00000269600.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048549846 |
Resistant |
| ENSG00000269911.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033802787 |
Resistant |
| ENSG00000269938.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019850856 |
Resistant |
| ENSG00000269997.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040833722 |
Resistant |
| ENSG00000270015.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022660876 |
Resistant |
| ENSG00000270055.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012502342 |
Resistant |
| ENSG00000271119.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030941929 |
Resistant |
| ENSG00000271737.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041410824 |
Resistant |
| ENSG00000271975.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020331271 |
Resistant |
| ENSG00000272211.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045066291 |
Resistant |
| ENSG00000272520.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035497111 |
Resistant |
| ENSG00000273061.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04803149 |
Resistant |
| ENSG00000273071.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034586273 |
Resistant |
| ENSG00000273190.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037730249 |
Resistant |
| ENSG00000205293.3 |
Nilotinib |
Esophageal cancer |
0.005516359 |
Resistant |
| ENSG00000213468.3 |
Nilotinib |
Esophageal cancer |
0.014254276 |
Resistant |
| ENSG00000224050.1 |
Nilotinib |
Esophageal cancer |
0.018199198 |
Resistant |
| ENSG00000235021.1 |
Nilotinib |
Esophageal cancer |
0.047076588 |
Resistant |
| ENSG00000236780.1 |
Nilotinib |
Esophageal cancer |
0.045778443 |
Resistant |
| ENSG00000248399.1 |
Nilotinib |
Esophageal cancer |
0.032773191 |
Resistant |
| ENSG00000250564.1 |
Nilotinib |
Esophageal cancer |
0.036487448 |
Resistant |
| ENSG00000255983.1 |
Nilotinib |
Esophageal cancer |
0.014418882 |
Resistant |
| ENSG00000257534.1 |
Nilotinib |
Esophageal cancer |
0.021434909 |
Resistant |
| ENSG00000259146.2 |
Nilotinib |
Esophageal cancer |
0.015720651 |
Resistant |
| ENSG00000261273.1 |
Nilotinib |
Esophageal cancer |
0.026248906 |
Resistant |
| ENSG00000261572.1 |
Nilotinib |
Esophageal cancer |
0.032046531 |
Resistant |
| ENSG00000265888.1 |
Nilotinib |
Esophageal cancer |
0.011246667 |
Resistant |
| ENSG00000266934.1 |
Nilotinib |
Esophageal cancer |
0.034060868 |
Resistant |
| ENSG00000272057.1 |
Nilotinib |
Esophageal cancer |
0.020481098 |
Resistant |
| ENSG00000188660.3 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.006809007 |
Resistant |
| ENSG00000189223.9 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.002960464 |
Resistant |
| ENSG00000229852.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.007789823 |
Resistant |
| ENSG00000234789.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.040387694 |
Resistant |
| ENSG00000237892.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.00357823 |
Resistant |
| ENSG00000244268.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.031324484 |
Resistant |
| ENSG00000246777.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.016029991 |
Resistant |
| ENSG00000251629.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.038583514 |
Resistant |
| ENSG00000256433.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.016927847 |
Resistant |
| ENSG00000257114.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.040692048 |
Resistant |
| ENSG00000257264.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.008072959 |
Resistant |
| ENSG00000257527.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.010735234 |
Resistant |
| ENSG00000259548.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.009780379 |
Resistant |
| ENSG00000261613.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.043602344 |
Resistant |
| ENSG00000264007.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.014692044 |
Resistant |
| ENSG00000266541.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.003550894 |
Resistant |
| ENSG00000266579.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.01167593 |
Resistant |
| ENSG00000268001.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.033418773 |
Resistant |
| ENSG00000268186.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.02036808 |
Resistant |
| ENSG00000269574.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.022762783 |
Resistant |
| ENSG00000272264.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.030284105 |
Resistant |
| ENSG00000272659.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.015170492 |
Resistant |
| ENSG00000160336.10 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.032387387 |
Resistant |
| ENSG00000182109.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.020046998 |
Resistant |
| ENSG00000204837.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.025908244 |
Resistant |
| ENSG00000205559.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.047038615 |
Resistant |
| ENSG00000212978.5 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.01247456 |
Resistant |
| ENSG00000223522.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.028720863 |
Resistant |
| ENSG00000223695.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.01099832 |
Resistant |
| ENSG00000223711.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.007941824 |
Resistant |
| ENSG00000223799.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.043933347 |
Resistant |
| ENSG00000224023.6 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.001429208 |
Resistant |
| ENSG00000224101.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.045084394 |
Resistant |
| ENSG00000224281.4 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.028114691 |
Resistant |
| ENSG00000224363.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.03972298 |
Resistant |
| ENSG00000224505.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.00418809 |
Resistant |
| ENSG00000225675.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.027491405 |
Resistant |
| ENSG00000225891.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.040936281 |
Resistant |
| ENSG00000225975.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.034291302 |
Resistant |
| ENSG00000226179.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.008544444 |
Resistant |
| ENSG00000226746.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.004559672 |
Resistant |
| ENSG00000227039.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.023088841 |
Resistant |
| ENSG00000227155.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.023202799 |
Resistant |
| ENSG00000227409.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.047235271 |
Resistant |
| ENSG00000227544.4 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.018789962 |
Resistant |
| ENSG00000228021.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.002653434 |
Resistant |
| ENSG00000228172.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.022301974 |
Resistant |
| ENSG00000228395.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.002731871 |
Resistant |
| ENSG00000228486.5 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.013388873 |
Resistant |
| ENSG00000228719.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.029347427 |
Resistant |
| ENSG00000228826.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.043126716 |
Resistant |
| ENSG00000228878.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.046948803 |
Resistant |
| ENSG00000229127.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.034198382 |
Resistant |
| ENSG00000229267.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.049901166 |
Resistant |
| ENSG00000229739.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.027619333 |
Resistant |
| ENSG00000229841.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.037608918 |
Resistant |
| ENSG00000229848.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.005763367 |
Resistant |
| ENSG00000230337.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.042362783 |
Resistant |
| ENSG00000230613.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.015374267 |
Resistant |
| ENSG00000231128.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.049363818 |
Resistant |
| ENSG00000231212.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.030773295 |
Resistant |
| ENSG00000231563.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.009261193 |
Resistant |
| ENSG00000231607.4 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.007362418 |
Resistant |
| ENSG00000231734.4 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.003721963 |
Resistant |
| ENSG00000232028.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.049003072 |
Resistant |
| ENSG00000232363.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.034556672 |
Resistant |
| ENSG00000232860.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.039252605 |
Resistant |
| ENSG00000233547.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.018469699 |
Resistant |
| ENSG00000233654.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.006781666 |
Resistant |
| ENSG00000234676.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.039885308 |
Resistant |
| ENSG00000234694.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.013054718 |
Resistant |
| ENSG00000234705.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.038817714 |
Resistant |
| ENSG00000234915.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.023704171 |
Resistant |
| ENSG00000235257.4 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.049590053 |
Resistant |
| ENSG00000235652.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.005397497 |
Resistant |
| ENSG00000236017.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.047456829 |
Resistant |
| ENSG00000236051.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.009886737 |
Resistant |
| ENSG00000236472.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.022102251 |
Resistant |
| ENSG00000236559.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.027676367 |
Resistant |
| ENSG00000236861.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.044402142 |
Resistant |
| ENSG00000236935.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.039636694 |
Resistant |
| ENSG00000237133.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.044979255 |
Resistant |
| ENSG00000237331.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.037344344 |
Resistant |
| ENSG00000237637.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.037587903 |
Resistant |
| ENSG00000238123.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.01303176 |
Resistant |
| ENSG00000238210.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.011649364 |
Resistant |
| ENSG00000240288.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.036182471 |
Resistant |
| ENSG00000240758.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.008016429 |
Resistant |
| ENSG00000240766.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.033134694 |
Resistant |
| ENSG00000241155.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.005498946 |
Resistant |
| ENSG00000241769.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.003216048 |
Resistant |
| ENSG00000241770.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.002096336 |
Resistant |
| ENSG00000241933.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.006078103 |
Resistant |
| ENSG00000243795.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.046321543 |
Resistant |
| ENSG00000244952.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.019158921 |
Resistant |
| ENSG00000245552.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.037803901 |
Resistant |
| ENSG00000246859.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.043113992 |
Resistant |
| ENSG00000247157.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.014072469 |
Resistant |
| ENSG00000247925.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.033186673 |
Resistant |
| ENSG00000249042.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.03378066 |
Resistant |
| ENSG00000249786.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.032568522 |
Resistant |
| ENSG00000249791.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.017944536 |
Resistant |
| ENSG00000249825.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.028134338 |
Resistant |
| ENSG00000250156.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.032035761 |
Resistant |
| ENSG00000250948.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.02632512 |
Resistant |
| ENSG00000251131.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.003655982 |
Resistant |
| ENSG00000253669.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.011503916 |
Resistant |
| ENSG00000253730.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.021363861 |
Resistant |
| ENSG00000253773.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.046742225 |
Resistant |
| ENSG00000253837.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.02138915 |
Resistant |
| ENSG00000254028.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.023309984 |
Resistant |
| ENSG00000254615.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.040097452 |
Resistant |
| ENSG00000254900.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.03758955 |
Resistant |
| ENSG00000255142.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.035460539 |
Resistant |
| ENSG00000255165.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.037850185 |
Resistant |
| ENSG00000255306.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.035408302 |
Resistant |
| ENSG00000255651.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.049625676 |
Resistant |
| ENSG00000255893.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.029981518 |
Resistant |
| ENSG00000256150.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.036035175 |
Resistant |
| ENSG00000257298.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.042854928 |
Resistant |
| ENSG00000257556.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.04259363 |
Resistant |
| ENSG00000258101.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.041743113 |
Resistant |
| ENSG00000258168.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.034170089 |
Resistant |
| ENSG00000258234.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.030069957 |
Resistant |
| ENSG00000258443.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.03960156 |
Resistant |
| ENSG00000258693.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.041186991 |
Resistant |
| ENSG00000258704.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.006061213 |
Resistant |
| ENSG00000259088.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.020729448 |
Resistant |
| ENSG00000259138.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.042355961 |
Resistant |
| ENSG00000259274.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.041615852 |
Resistant |
| ENSG00000259826.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.038064309 |
Resistant |
| ENSG00000260219.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.010226135 |
Resistant |
| ENSG00000260352.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.010752534 |
Resistant |
| ENSG00000260475.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.042504875 |
Resistant |
| ENSG00000260493.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.028485973 |
Resistant |
| ENSG00000260495.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.014105273 |
Resistant |
| ENSG00000260672.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.02985273 |
Resistant |
| ENSG00000260778.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.025715732 |
Resistant |
| ENSG00000260796.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.007964306 |
Resistant |
| ENSG00000261000.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.02256278 |
Resistant |
| ENSG00000261105.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.035520088 |
Resistant |
| ENSG00000261118.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.003273471 |
Resistant |
| ENSG00000261396.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.024948491 |
Resistant |
| ENSG00000261471.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.002322585 |
Resistant |
| ENSG00000261823.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.016408319 |
Resistant |
| ENSG00000261840.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.029967718 |
Resistant |
| ENSG00000266912.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.03262126 |
Resistant |
| ENSG00000266999.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.029034859 |
Resistant |
| ENSG00000267212.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.011976085 |
Resistant |
| ENSG00000267230.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.046235482 |
Resistant |
| ENSG00000267344.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.012267137 |
Resistant |
| ENSG00000267348.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.00321024 |
Resistant |
| ENSG00000267834.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.041658065 |
Resistant |
| ENSG00000268061.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.027662889 |
Resistant |
| ENSG00000268204.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.030217395 |
Resistant |
| ENSG00000269202.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.041098306 |
Resistant |
| ENSG00000269290.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.029526269 |
Resistant |
| ENSG00000269534.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.000909536 |
Resistant |
| ENSG00000270006.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.036341895 |
Resistant |
| ENSG00000270019.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.048494741 |
Resistant |
| ENSG00000270049.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.049477779 |
Resistant |
| ENSG00000270115.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.048643975 |
Resistant |
| ENSG00000270140.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.015564782 |
Resistant |
| ENSG00000270571.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.03922501 |
Resistant |
| ENSG00000270951.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.036809507 |
Resistant |
| ENSG00000271742.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.044567892 |
Resistant |
| ENSG00000271752.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.035732396 |
Resistant |
| ENSG00000271757.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.029249924 |
Resistant |
| ENSG00000271889.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.022067791 |
Resistant |
| ENSG00000272024.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.03831918 |
Resistant |
| ENSG00000272070.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.01484614 |
Resistant |
| ENSG00000272092.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.048687185 |
Resistant |
| ENSG00000272662.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.047265139 |
Resistant |
| ENSG00000272663.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.03225685 |
Resistant |
| ENSG00000272692.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.025372068 |
Resistant |
| ENSG00000272746.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.024661193 |
Resistant |
| ENSG00000272825.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.02398356 |
Resistant |
| ENSG00000272940.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.041662665 |
Resistant |
| ENSG00000272979.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.001702451 |
Resistant |
| ENSG00000273004.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.006462304 |
Resistant |
| ENSG00000273026.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.041880833 |
Resistant |
| ENSG00000273198.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.034981839 |
Resistant |
| ENSG00000273329.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.009218052 |
Resistant |
| ENSG00000273406.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.039560417 |
Resistant |
| ENSG00000273424.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.018649539 |
Resistant |
| ENSG00000273428.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.000973313 |
Resistant |
| ENSG00000180139.10 |
Nilotinib |
Brain lower grade glioma |
0.015464127 |
Resistant |
| ENSG00000205037.2 |
Nilotinib |
Brain lower grade glioma |
0.019052197 |
Resistant |
| ENSG00000215159.3 |
Nilotinib |
Brain lower grade glioma |
0.008424298 |
Resistant |
| ENSG00000224799.1 |
Nilotinib |
Brain lower grade glioma |
0.046667884 |
Resistant |
| ENSG00000225037.1 |
Nilotinib |
Brain lower grade glioma |
0.01727335 |
Resistant |
| ENSG00000225163.3 |
Nilotinib |
Brain lower grade glioma |
0.036524634 |
Resistant |
| ENSG00000225335.2 |
Nilotinib |
Brain lower grade glioma |
0.034318873 |
Resistant |
| ENSG00000226688.2 |
Nilotinib |
Brain lower grade glioma |
0.037837498 |
Resistant |
| ENSG00000227245.1 |
Nilotinib |
Brain lower grade glioma |
0.003058333 |
Resistant |
| ENSG00000227540.1 |
Nilotinib |
Brain lower grade glioma |
0.022812889 |
Resistant |
| ENSG00000227906.3 |
Nilotinib |
Brain lower grade glioma |
0.049606044 |
Resistant |
| ENSG00000228022.1 |
Nilotinib |
Brain lower grade glioma |
0.009547297 |
Resistant |
| ENSG00000228242.3 |
Nilotinib |
Brain lower grade glioma |
0.016509028 |
Resistant |
| ENSG00000228629.2 |
Nilotinib |
Brain lower grade glioma |
0.042453599 |
Resistant |
| ENSG00000228723.2 |
Nilotinib |
Brain lower grade glioma |
0.010823888 |
Resistant |
| ENSG00000229214.1 |
Nilotinib |
Brain lower grade glioma |
0.047859699 |
Resistant |
| ENSG00000229666.1 |
Nilotinib |
Brain lower grade glioma |
0.033868835 |
Resistant |
| ENSG00000229766.2 |
Nilotinib |
Brain lower grade glioma |
0.046168162 |
Resistant |
| ENSG00000229832.1 |
Nilotinib |
Brain lower grade glioma |
0.034225389 |
Resistant |
| ENSG00000230506.1 |
Nilotinib |
Brain lower grade glioma |
0.012167247 |
Resistant |
| ENSG00000230612.1 |
Nilotinib |
Brain lower grade glioma |
0.008664057 |
Resistant |
| ENSG00000230732.3 |
Nilotinib |
Brain lower grade glioma |
0.004685611 |
Resistant |
| ENSG00000232633.3 |
Nilotinib |
Brain lower grade glioma |
0.013248797 |
Resistant |
| ENSG00000232693.2 |
Nilotinib |
Brain lower grade glioma |
0.010154675 |
Resistant |
| ENSG00000232811.1 |
Nilotinib |
Brain lower grade glioma |
0.036260013 |
Resistant |
| ENSG00000232828.1 |
Nilotinib |
Brain lower grade glioma |
0.016895745 |
Resistant |
| ENSG00000232876.1 |
Nilotinib |
Brain lower grade glioma |
0.039588425 |
Resistant |
| ENSG00000234252.1 |
Nilotinib |
Brain lower grade glioma |
0.036842989 |
Resistant |
| ENSG00000235079.1 |
Nilotinib |
Brain lower grade glioma |
0.047430187 |
Resistant |
| ENSG00000235373.1 |
Nilotinib |
Brain lower grade glioma |
0.02933863 |
Resistant |
| ENSG00000235609.4 |
Nilotinib |
Brain lower grade glioma |
0.00678066 |
Resistant |
| ENSG00000235795.1 |
Nilotinib |
Brain lower grade glioma |
0.03024081 |
Resistant |
| ENSG00000235908.1 |
Nilotinib |
Brain lower grade glioma |
0.010486953 |
Resistant |
| ENSG00000235947.1 |
Nilotinib |
Brain lower grade glioma |
0.021878241 |
Resistant |
| ENSG00000236545.1 |
Nilotinib |
Brain lower grade glioma |
0.016905032 |
Resistant |
| ENSG00000237021.2 |
Nilotinib |
Brain lower grade glioma |
0.020478145 |
Resistant |
| ENSG00000237502.2 |
Nilotinib |
Brain lower grade glioma |
0.027744763 |
Resistant |
| ENSG00000240401.4 |
Nilotinib |
Brain lower grade glioma |
0.02647099 |
Resistant |
| ENSG00000240549.2 |
Nilotinib |
Brain lower grade glioma |
0.023817956 |
Resistant |
| ENSG00000240618.1 |
Nilotinib |
Brain lower grade glioma |
0.039489018 |
Resistant |
| ENSG00000244265.1 |
Nilotinib |
Brain lower grade glioma |
0.031986748 |
Resistant |
| ENSG00000244513.2 |
Nilotinib |
Brain lower grade glioma |
0.039044835 |
Resistant |
| ENSG00000248243.1 |
Nilotinib |
Brain lower grade glioma |
0.033807322 |
Resistant |
| ENSG00000248671.3 |
Nilotinib |
Brain lower grade glioma |
0.032807702 |
Resistant |
| ENSG00000248724.2 |
Nilotinib |
Brain lower grade glioma |
0.024697275 |
Resistant |
| ENSG00000249635.1 |
Nilotinib |
Brain lower grade glioma |
0.040406578 |
Resistant |
| ENSG00000249685.1 |
Nilotinib |
Brain lower grade glioma |
0.013602565 |
Resistant |
| ENSG00000250260.1 |
Nilotinib |
Brain lower grade glioma |
0.019886756 |
Resistant |
| ENSG00000250410.1 |
Nilotinib |
Brain lower grade glioma |
0.030385414 |
Resistant |
| ENSG00000250950.1 |
Nilotinib |
Brain lower grade glioma |
0.005343917 |
Resistant |
| ENSG00000251022.2 |
Nilotinib |
Brain lower grade glioma |
0.011473513 |
Resistant |
| ENSG00000253390.1 |
Nilotinib |
Brain lower grade glioma |
0.028628884 |
Resistant |
| ENSG00000253986.1 |
Nilotinib |
Brain lower grade glioma |
0.01118783 |
Resistant |
| ENSG00000254226.1 |
Nilotinib |
Brain lower grade glioma |
0.038194873 |
Resistant |
| ENSG00000254263.1 |
Nilotinib |
Brain lower grade glioma |
0.047946821 |
Resistant |
| ENSG00000254485.1 |
Nilotinib |
Brain lower grade glioma |
0.01360344 |
Resistant |
| ENSG00000254551.1 |
Nilotinib |
Brain lower grade glioma |
0.041322372 |
Resistant |
| ENSG00000255164.1 |
Nilotinib |
Brain lower grade glioma |
0.047436897 |
Resistant |
| ENSG00000256747.1 |
Nilotinib |
Brain lower grade glioma |
0.014259728 |
Resistant |
| ENSG00000257279.1 |
Nilotinib |
Brain lower grade glioma |
0.014714175 |
Resistant |
| ENSG00000257621.3 |
Nilotinib |
Brain lower grade glioma |
0.011125963 |
Resistant |
| ENSG00000257696.1 |
Nilotinib |
Brain lower grade glioma |
0.042445176 |
Resistant |
| ENSG00000257759.2 |
Nilotinib |
Brain lower grade glioma |
0.047990958 |
Resistant |
| ENSG00000258048.1 |
Nilotinib |
Brain lower grade glioma |
0.015400584 |
Resistant |
| ENSG00000258172.1 |
Nilotinib |
Brain lower grade glioma |
0.045104955 |
Resistant |
| ENSG00000258302.1 |
Nilotinib |
Brain lower grade glioma |
0.03732173 |
Resistant |
| ENSG00000258424.1 |
Nilotinib |
Brain lower grade glioma |
0.033224514 |
Resistant |
| ENSG00000258458.1 |
Nilotinib |
Brain lower grade glioma |
0.044689649 |
Resistant |
| ENSG00000258623.1 |
Nilotinib |
Brain lower grade glioma |
0.026967787 |
Resistant |
| ENSG00000258633.1 |
Nilotinib |
Brain lower grade glioma |
0.033216111 |
Resistant |
| ENSG00000258682.1 |
Nilotinib |
Brain lower grade glioma |
0.008775024 |
Resistant |
| ENSG00000259153.1 |
Nilotinib |
Brain lower grade glioma |
0.032330781 |
Resistant |
| ENSG00000259298.1 |
Nilotinib |
Brain lower grade glioma |
0.025413013 |
Resistant |
| ENSG00000259364.1 |
Nilotinib |
Brain lower grade glioma |
0.027140695 |
Resistant |
| ENSG00000259488.1 |
Nilotinib |
Brain lower grade glioma |
0.033500673 |
Resistant |
| ENSG00000259818.1 |
Nilotinib |
Brain lower grade glioma |
0.000097 |
Resistant |
| ENSG00000259953.1 |
Nilotinib |
Brain lower grade glioma |
0.023805402 |
Resistant |
| ENSG00000259986.1 |
Nilotinib |
Brain lower grade glioma |
0.023054369 |
Resistant |
| ENSG00000260000.2 |
Nilotinib |
Brain lower grade glioma |
0.019842415 |
Resistant |
| ENSG00000260093.1 |
Nilotinib |
Brain lower grade glioma |
0.00309663 |
Resistant |
| ENSG00000260273.1 |
Nilotinib |
Brain lower grade glioma |
0.002532454 |
Resistant |
| ENSG00000260366.1 |
Nilotinib |
Brain lower grade glioma |
0.018621755 |
Resistant |
| ENSG00000260774.1 |
Nilotinib |
Brain lower grade glioma |
0.044551452 |
Resistant |
| ENSG00000260793.2 |
Nilotinib |
Brain lower grade glioma |
0.043898233 |
Resistant |
| ENSG00000260884.1 |
Nilotinib |
Brain lower grade glioma |
0.038508892 |
Resistant |
| ENSG00000261131.1 |
Nilotinib |
Brain lower grade glioma |
0.026514867 |
Resistant |
| ENSG00000261357.1 |
Nilotinib |
Brain lower grade glioma |
0.00000225 |
Resistant |
| ENSG00000261433.1 |
Nilotinib |
Brain lower grade glioma |
0.033518754 |
Resistant |
| ENSG00000261476.1 |
Nilotinib |
Brain lower grade glioma |
0.011939881 |
Resistant |
| ENSG00000261533.1 |
Nilotinib |
Brain lower grade glioma |
0.043578481 |
Resistant |
| ENSG00000262222.1 |
Nilotinib |
Brain lower grade glioma |
0.032172262 |
Resistant |
| ENSG00000263013.1 |
Nilotinib |
Brain lower grade glioma |
0.012200162 |
Resistant |
| ENSG00000263033.1 |
Nilotinib |
Brain lower grade glioma |
0.041614783 |
Resistant |
| ENSG00000263338.1 |
Nilotinib |
Brain lower grade glioma |
0.034486718 |
Resistant |
| ENSG00000263345.1 |
Nilotinib |
Brain lower grade glioma |
0.020553578 |
Resistant |
| ENSG00000265912.1 |
Nilotinib |
Brain lower grade glioma |
0.001764063 |
Resistant |
| ENSG00000267298.1 |
Nilotinib |
Brain lower grade glioma |
0.025547518 |
Resistant |
| ENSG00000267834.1 |
Nilotinib |
Brain lower grade glioma |
0.04175189 |
Resistant |
| ENSG00000268015.1 |
Nilotinib |
Brain lower grade glioma |
0.038294025 |
Resistant |
| ENSG00000268307.1 |
Nilotinib |
Brain lower grade glioma |
0.043102085 |
Resistant |
| ENSG00000268564.1 |
Nilotinib |
Brain lower grade glioma |
0.006337762 |
Resistant |
| ENSG00000268670.1 |
Nilotinib |
Brain lower grade glioma |
0.026794199 |
Resistant |
| ENSG00000269444.1 |
Nilotinib |
Brain lower grade glioma |
0.026341479 |
Resistant |
| ENSG00000269653.1 |
Nilotinib |
Brain lower grade glioma |
0.021522777 |
Resistant |
| ENSG00000269999.1 |
Nilotinib |
Brain lower grade glioma |
0.039121284 |
Resistant |
| ENSG00000270332.1 |
Nilotinib |
Brain lower grade glioma |
0.044301474 |
Resistant |
| ENSG00000271119.1 |
Nilotinib |
Brain lower grade glioma |
0.041153111 |
Resistant |
| ENSG00000271914.1 |
Nilotinib |
Brain lower grade glioma |
0.024689217 |
Resistant |
| ENSG00000271964.1 |
Nilotinib |
Brain lower grade glioma |
0.037867934 |
Resistant |
| ENSG00000271991.1 |
Nilotinib |
Brain lower grade glioma |
0.018526009 |
Resistant |
| ENSG00000271993.1 |
Nilotinib |
Brain lower grade glioma |
0.008200687 |
Resistant |
| ENSG00000272205.1 |
Nilotinib |
Brain lower grade glioma |
0.029519165 |
Resistant |
| ENSG00000272744.1 |
Nilotinib |
Brain lower grade glioma |
0.04355197 |
Resistant |
| ENSG00000272764.1 |
Nilotinib |
Brain lower grade glioma |
0.022253574 |
Resistant |
| ENSG00000272933.1 |
Nilotinib |
Brain lower grade glioma |
0.002575212 |
Resistant |
| ENSG00000273162.1 |
Nilotinib |
Brain lower grade glioma |
0.037691679 |
Resistant |
| ENSG00000273247.1 |
Nilotinib |
Brain lower grade glioma |
0.015556158 |
Resistant |
| ENSG00000273290.1 |
Nilotinib |
Brain lower grade glioma |
0.044359869 |
Resistant |
| ENSG00000273297.1 |
Nilotinib |
Brain lower grade glioma |
0.028610592 |
Resistant |
| ENSG00000178977.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.013826033 |
Resistant |
| ENSG00000204949.4 |
Nilotinib |
Lung squamous cell carcinoma |
0.017067343 |
Resistant |
| ENSG00000206567.5 |
Nilotinib |
Lung squamous cell carcinoma |
0.023891581 |
Resistant |
| ENSG00000224638.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.043761531 |
Resistant |
| ENSG00000224863.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.038465152 |
Resistant |
| ENSG00000226453.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.044231749 |
Resistant |
| ENSG00000228113.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.015211648 |
Resistant |
| ENSG00000228526.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.045719713 |
Resistant |
| ENSG00000230046.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.018668027 |
Resistant |
| ENSG00000230316.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.024783578 |
Resistant |
| ENSG00000230789.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.030017844 |
Resistant |
| ENSG00000231291.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.030023101 |
Resistant |
| ENSG00000231334.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.027059176 |
Resistant |
| ENSG00000232164.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.038292981 |
Resistant |
| ENSG00000233017.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.016405241 |
Resistant |
| ENSG00000233030.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.03856317 |
Resistant |
| ENSG00000233251.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.035453091 |
Resistant |
| ENSG00000233783.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.030797099 |
Resistant |
| ENSG00000234076.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.03794472 |
Resistant |
| ENSG00000234427.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.046277489 |
Resistant |
| ENSG00000237614.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.01694133 |
Resistant |
| ENSG00000240423.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.022247574 |
Resistant |
| ENSG00000241135.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.04740994 |
Resistant |
| ENSG00000241544.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.04677085 |
Resistant |
| ENSG00000242104.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.031122245 |
Resistant |
| ENSG00000244265.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.020493686 |
Resistant |
| ENSG00000244791.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.046661317 |
Resistant |
| ENSG00000248973.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.044590902 |
Resistant |
| ENSG00000249647.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.015501029 |
Resistant |
| ENSG00000251169.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.040192359 |
Resistant |
| ENSG00000251574.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.046467063 |
Resistant |
| ENSG00000254484.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.029043011 |
Resistant |
| ENSG00000254762.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.034175465 |
Resistant |
| ENSG00000255364.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.045710431 |
Resistant |
| ENSG00000255422.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.01813925 |
Resistant |
| ENSG00000255741.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.026842081 |
Resistant |
| ENSG00000256564.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.021795372 |
Resistant |
| ENSG00000257488.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.014635121 |
Resistant |
| ENSG00000258689.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.021815961 |
Resistant |
| ENSG00000258752.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.013054737 |
Resistant |
| ENSG00000258897.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.048956292 |
Resistant |
| ENSG00000260418.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.038997396 |
Resistant |
| ENSG00000260586.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.008490073 |
Resistant |
| ENSG00000260660.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.022598586 |
Resistant |
| ENSG00000260744.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.025383879 |
Resistant |
| ENSG00000261521.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.015722389 |
Resistant |
| ENSG00000261574.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.023596465 |
Resistant |
| ENSG00000261760.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.016712465 |
Resistant |
| ENSG00000263214.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.037064728 |
Resistant |
| ENSG00000264868.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.029058298 |
Resistant |
| ENSG00000266541.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.01194765 |
Resistant |
| ENSG00000267095.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.04567011 |
Resistant |
| ENSG00000267255.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.041927358 |
Resistant |
| ENSG00000267798.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.012769816 |
Resistant |
| ENSG00000268015.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.010458296 |
Resistant |
| ENSG00000268833.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.042820052 |
Resistant |
| ENSG00000269934.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.046528672 |
Resistant |
| ENSG00000272482.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.035696109 |
Resistant |
| ENSG00000272549.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.048330722 |
Resistant |
| ENSG00000273174.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.016148979 |
Resistant |
| ENSG00000224216.1 |
Nilotinib |
Sarcoma |
0.037245482 |
Resistant |
| ENSG00000224409.1 |
Nilotinib |
Sarcoma |
0.021393852 |
Resistant |
| ENSG00000224533.3 |
Nilotinib |
Sarcoma |
0.003781343 |
Resistant |
| ENSG00000225393.1 |
Nilotinib |
Sarcoma |
0.006079463 |
Resistant |
| ENSG00000231104.4 |
Nilotinib |
Sarcoma |
0.045138651 |
Resistant |
| ENSG00000232455.2 |
Nilotinib |
Sarcoma |
0.032322793 |
Resistant |
| ENSG00000232912.1 |
Nilotinib |
Sarcoma |
0.012717115 |
Resistant |
| ENSG00000233926.1 |
Nilotinib |
Sarcoma |
0.047729642 |
Resistant |
| ENSG00000234509.1 |
Nilotinib |
Sarcoma |
0.049531455 |
Resistant |
| ENSG00000235426.2 |
Nilotinib |
Sarcoma |
0.038966239 |
Resistant |
| ENSG00000235450.1 |
Nilotinib |
Sarcoma |
0.021005662 |
Resistant |
| ENSG00000237149.4 |
Nilotinib |
Sarcoma |
0.03142012 |
Resistant |
| ENSG00000241560.1 |
Nilotinib |
Sarcoma |
0.0437764 |
Resistant |
| ENSG00000243433.1 |
Nilotinib |
Sarcoma |
0.01116433 |
Resistant |
| ENSG00000250116.2 |
Nilotinib |
Sarcoma |
0.018169431 |
Resistant |
| ENSG00000255159.1 |
Nilotinib |
Sarcoma |
0.015026573 |
Resistant |
| ENSG00000259520.1 |
Nilotinib |
Sarcoma |
0.00168742 |
Resistant |
| ENSG00000260917.1 |
Nilotinib |
Sarcoma |
0.034169552 |
Resistant |
| ENSG00000261842.1 |
Nilotinib |
Sarcoma |
0.00419876 |
Resistant |
| ENSG00000262115.1 |
Nilotinib |
Sarcoma |
0.009263175 |
Resistant |
| ENSG00000263627.1 |
Nilotinib |
Sarcoma |
0.020541291 |
Resistant |
| ENSG00000263718.2 |
Nilotinib |
Sarcoma |
0.019334124 |
Resistant |
| ENSG00000264546.1 |
Nilotinib |
Sarcoma |
0.025885284 |
Resistant |
| ENSG00000265094.1 |
Nilotinib |
Sarcoma |
0.043417902 |
Resistant |
| ENSG00000266921.1 |
Nilotinib |
Sarcoma |
0.002044559 |
Resistant |
| ENSG00000267302.1 |
Nilotinib |
Sarcoma |
0.013939239 |
Resistant |
| ENSG00000268520.1 |
Nilotinib |
Sarcoma |
0.002376954 |
Resistant |
| ENSG00000269903.1 |
Nilotinib |
Sarcoma |
0.039880674 |
Resistant |
| ENSG00000269946.1 |
Nilotinib |
Sarcoma |
0.000806226 |
Resistant |
| ENSG00000270604.1 |
Nilotinib |
Sarcoma |
0.0134037 |
Resistant |
| ENSG00000271761.1 |
Nilotinib |
Sarcoma |
0.036114856 |
Resistant |
| ENSG00000104691.10 |
Nilotinib |
Skin cutaneous melanoma |
0.021769226 |
Resistant |
| ENSG00000180279.5 |
Nilotinib |
Skin cutaneous melanoma |
0.039306662 |
Resistant |
| ENSG00000189149.7 |
Nilotinib |
Skin cutaneous melanoma |
0.016769248 |
Resistant |
| ENSG00000198468.3 |
Nilotinib |
Skin cutaneous melanoma |
0.025288327 |
Resistant |
| ENSG00000204758.3 |
Nilotinib |
Skin cutaneous melanoma |
0.03354005 |
Resistant |
| ENSG00000206417.4 |
Nilotinib |
Skin cutaneous melanoma |
0.001427478 |
Resistant |
| ENSG00000224031.1 |
Nilotinib |
Skin cutaneous melanoma |
0.0341931 |
Resistant |
| ENSG00000224614.1 |
Nilotinib |
Skin cutaneous melanoma |
0.00604362 |
Resistant |
| ENSG00000224959.1 |
Nilotinib |
Skin cutaneous melanoma |
0.026683756 |
Resistant |
| ENSG00000225032.1 |
Nilotinib |
Skin cutaneous melanoma |
0.042570862 |
Resistant |
| ENSG00000225084.1 |
Nilotinib |
Skin cutaneous melanoma |
0.032467544 |
Resistant |
| ENSG00000225213.2 |
Nilotinib |
Skin cutaneous melanoma |
0.037406922 |
Resistant |
| ENSG00000226649.1 |
Nilotinib |
Skin cutaneous melanoma |
0.046403686 |
Resistant |
| ENSG00000227110.2 |
Nilotinib |
Skin cutaneous melanoma |
0.028897447 |
Resistant |
| ENSG00000227161.1 |
Nilotinib |
Skin cutaneous melanoma |
0.003430046 |
Resistant |
| ENSG00000227516.1 |
Nilotinib |
Skin cutaneous melanoma |
0.005993869 |
Resistant |
| ENSG00000229832.1 |
Nilotinib |
Skin cutaneous melanoma |
0.033954153 |
Resistant |
| ENSG00000230289.1 |
Nilotinib |
Skin cutaneous melanoma |
0.04394878 |
Resistant |
| ENSG00000230530.1 |
Nilotinib |
Skin cutaneous melanoma |
0.011522373 |
Resistant |
| ENSG00000231081.1 |
Nilotinib |
Skin cutaneous melanoma |
0.023022793 |
Resistant |
| ENSG00000231154.1 |
Nilotinib |
Skin cutaneous melanoma |
0.018110196 |
Resistant |
| ENSG00000231294.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024139868 |
Resistant |
| ENSG00000232028.1 |
Nilotinib |
Skin cutaneous melanoma |
0.045555676 |
Resistant |
| ENSG00000232043.1 |
Nilotinib |
Skin cutaneous melanoma |
0.042134648 |
Resistant |
| ENSG00000232442.1 |
Nilotinib |
Skin cutaneous melanoma |
0.015118328 |
Resistant |
| ENSG00000232485.2 |
Nilotinib |
Skin cutaneous melanoma |
0.048662509 |
Resistant |
| ENSG00000232940.1 |
Nilotinib |
Skin cutaneous melanoma |
0.0000384 |
Resistant |
| ENSG00000232987.1 |
Nilotinib |
Skin cutaneous melanoma |
0.000570273 |
Resistant |
| ENSG00000233338.1 |
Nilotinib |
Skin cutaneous melanoma |
0.037624724 |
Resistant |
| ENSG00000235159.1 |
Nilotinib |
Skin cutaneous melanoma |
0.037169854 |
Resistant |
| ENSG00000235629.1 |
Nilotinib |
Skin cutaneous melanoma |
0.036673044 |
Resistant |
| ENSG00000235908.1 |
Nilotinib |
Skin cutaneous melanoma |
0.031658269 |
Resistant |
| ENSG00000236463.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024890432 |
Resistant |
| ENSG00000236519.1 |
Nilotinib |
Skin cutaneous melanoma |
0.003511173 |
Resistant |
| ENSG00000236935.1 |
Nilotinib |
Skin cutaneous melanoma |
0.039356781 |
Resistant |
| ENSG00000237399.3 |
Nilotinib |
Skin cutaneous melanoma |
0.009743983 |
Resistant |
| ENSG00000238260.1 |
Nilotinib |
Skin cutaneous melanoma |
0.02392525 |
Resistant |
| ENSG00000239674.2 |
Nilotinib |
Skin cutaneous melanoma |
0.041959543 |
Resistant |
| ENSG00000243368.2 |
Nilotinib |
Skin cutaneous melanoma |
0.011868816 |
Resistant |
| ENSG00000245149.3 |
Nilotinib |
Skin cutaneous melanoma |
0.00284658 |
Resistant |
| ENSG00000246323.2 |
Nilotinib |
Skin cutaneous melanoma |
0.006532146 |
Resistant |
| ENSG00000247240.3 |
Nilotinib |
Skin cutaneous melanoma |
0.001671644 |
Resistant |
| ENSG00000248537.1 |
Nilotinib |
Skin cutaneous melanoma |
0.033099097 |
Resistant |
| ENSG00000248774.1 |
Nilotinib |
Skin cutaneous melanoma |
0.003353889 |
Resistant |
| ENSG00000248968.1 |
Nilotinib |
Skin cutaneous melanoma |
0.027037924 |
Resistant |
| ENSG00000249791.1 |
Nilotinib |
Skin cutaneous melanoma |
0.026430344 |
Resistant |
| ENSG00000250988.3 |
Nilotinib |
Skin cutaneous melanoma |
0.009036346 |
Resistant |
| ENSG00000253829.1 |
Nilotinib |
Skin cutaneous melanoma |
0.041999839 |
Resistant |
| ENSG00000254258.1 |
Nilotinib |
Skin cutaneous melanoma |
0.021785115 |
Resistant |
| ENSG00000255031.1 |
Nilotinib |
Skin cutaneous melanoma |
0.019010375 |
Resistant |
| ENSG00000255237.1 |
Nilotinib |
Skin cutaneous melanoma |
0.027590395 |
Resistant |
| ENSG00000255306.1 |
Nilotinib |
Skin cutaneous melanoma |
0.040470731 |
Resistant |
| ENSG00000256588.1 |
Nilotinib |
Skin cutaneous melanoma |
0.033248493 |
Resistant |
| ENSG00000258136.1 |
Nilotinib |
Skin cutaneous melanoma |
0.043798244 |
Resistant |
| ENSG00000259006.1 |
Nilotinib |
Skin cutaneous melanoma |
0.002837611 |
Resistant |
| ENSG00000259349.1 |
Nilotinib |
Skin cutaneous melanoma |
0.016086325 |
Resistant |
| ENSG00000259654.1 |
Nilotinib |
Skin cutaneous melanoma |
0.006432473 |
Resistant |
| ENSG00000259736.1 |
Nilotinib |
Skin cutaneous melanoma |
0.023466232 |
Resistant |
| ENSG00000259883.1 |
Nilotinib |
Skin cutaneous melanoma |
0.017138317 |
Resistant |
| ENSG00000260167.1 |
Nilotinib |
Skin cutaneous melanoma |
0.015949073 |
Resistant |
| ENSG00000260285.1 |
Nilotinib |
Skin cutaneous melanoma |
0.031367922 |
Resistant |
| ENSG00000260589.1 |
Nilotinib |
Skin cutaneous melanoma |
0.009806277 |
Resistant |
| ENSG00000260591.1 |
Nilotinib |
Skin cutaneous melanoma |
0.032768564 |
Resistant |
| ENSG00000260664.1 |
Nilotinib |
Skin cutaneous melanoma |
0.042676861 |
Resistant |
| ENSG00000260743.1 |
Nilotinib |
Skin cutaneous melanoma |
0.0000866 |
Resistant |
| ENSG00000260778.2 |
Nilotinib |
Skin cutaneous melanoma |
0.011505102 |
Resistant |
| ENSG00000260803.1 |
Nilotinib |
Skin cutaneous melanoma |
0.047750244 |
Resistant |
| ENSG00000261008.2 |
Nilotinib |
Skin cutaneous melanoma |
0.019111919 |
Resistant |
| ENSG00000261386.2 |
Nilotinib |
Skin cutaneous melanoma |
0.04761961 |
Resistant |
| ENSG00000261864.1 |
Nilotinib |
Skin cutaneous melanoma |
0.046937728 |
Resistant |
| ENSG00000262228.1 |
Nilotinib |
Skin cutaneous melanoma |
0.031951647 |
Resistant |
| ENSG00000262703.1 |
Nilotinib |
Skin cutaneous melanoma |
0.045517047 |
Resistant |
| ENSG00000263050.1 |
Nilotinib |
Skin cutaneous melanoma |
0.0074532 |
Resistant |
| ENSG00000263412.1 |
Nilotinib |
Skin cutaneous melanoma |
0.046526077 |
Resistant |
| ENSG00000263975.1 |
Nilotinib |
Skin cutaneous melanoma |
0.031735909 |
Resistant |
| ENSG00000265010.1 |
Nilotinib |
Skin cutaneous melanoma |
0.018613274 |
Resistant |
| ENSG00000265625.1 |
Nilotinib |
Skin cutaneous melanoma |
0.049853582 |
Resistant |
| ENSG00000266717.1 |
Nilotinib |
Skin cutaneous melanoma |
0.005955982 |
Resistant |
| ENSG00000267003.1 |
Nilotinib |
Skin cutaneous melanoma |
0.011603774 |
Resistant |
| ENSG00000267273.1 |
Nilotinib |
Skin cutaneous melanoma |
0.023643987 |
Resistant |
| ENSG00000267289.1 |
Nilotinib |
Skin cutaneous melanoma |
0.01889697 |
Resistant |
| ENSG00000267383.2 |
Nilotinib |
Skin cutaneous melanoma |
0.009350221 |
Resistant |
| ENSG00000267481.1 |
Nilotinib |
Skin cutaneous melanoma |
0.043969072 |
Resistant |
| ENSG00000268938.2 |
Nilotinib |
Skin cutaneous melanoma |
0.005318961 |
Resistant |
| ENSG00000269161.1 |
Nilotinib |
Skin cutaneous melanoma |
0.047693054 |
Resistant |
| ENSG00000269397.1 |
Nilotinib |
Skin cutaneous melanoma |
0.009512204 |
Resistant |
| ENSG00000269938.1 |
Nilotinib |
Skin cutaneous melanoma |
0.006432897 |
Resistant |
| ENSG00000269946.1 |
Nilotinib |
Skin cutaneous melanoma |
0.012125719 |
Resistant |
| ENSG00000270019.1 |
Nilotinib |
Skin cutaneous melanoma |
0.014379215 |
Resistant |
| ENSG00000270061.1 |
Nilotinib |
Skin cutaneous melanoma |
0.0035186 |
Resistant |
| ENSG00000270095.1 |
Nilotinib |
Skin cutaneous melanoma |
0.016673974 |
Resistant |
| ENSG00000270168.1 |
Nilotinib |
Skin cutaneous melanoma |
0.033305765 |
Resistant |
| ENSG00000270190.1 |
Nilotinib |
Skin cutaneous melanoma |
0.008517363 |
Resistant |
| ENSG00000270426.1 |
Nilotinib |
Skin cutaneous melanoma |
0.041391136 |
Resistant |
| ENSG00000270557.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024144971 |
Resistant |
| ENSG00000271843.1 |
Nilotinib |
Skin cutaneous melanoma |
0.007752695 |
Resistant |
| ENSG00000271963.1 |
Nilotinib |
Skin cutaneous melanoma |
0.03393461 |
Resistant |
| ENSG00000271993.1 |
Nilotinib |
Skin cutaneous melanoma |
0.030428601 |
Resistant |
| ENSG00000271997.1 |
Nilotinib |
Skin cutaneous melanoma |
0.010710942 |
Resistant |
| ENSG00000272265.1 |
Nilotinib |
Skin cutaneous melanoma |
0.038620328 |
Resistant |
| ENSG00000272452.1 |
Nilotinib |
Skin cutaneous melanoma |
0.0066967 |
Resistant |
| ENSG00000272457.1 |
Nilotinib |
Skin cutaneous melanoma |
0.034354267 |
Resistant |
| ENSG00000272662.1 |
Nilotinib |
Skin cutaneous melanoma |
0.028289281 |
Resistant |
| ENSG00000272721.1 |
Nilotinib |
Skin cutaneous melanoma |
0.032573769 |
Resistant |
| ENSG00000272862.1 |
Nilotinib |
Skin cutaneous melanoma |
0.003927961 |
Resistant |
| ENSG00000272983.1 |
Nilotinib |
Skin cutaneous melanoma |
0.001415128 |
Resistant |
| ENSG00000273001.1 |
Nilotinib |
Skin cutaneous melanoma |
0.04380703 |
Resistant |
| ENSG00000273019.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024548253 |
Resistant |
| ENSG00000273445.1 |
Nilotinib |
Skin cutaneous melanoma |
0.008429514 |
Resistant |
| ENSG00000225489.2 |
Nilotinib |
Stomach adenocarcinoma |
0.016610468 |
Resistant |
| ENSG00000229521.2 |
Nilotinib |
Stomach adenocarcinoma |
0.037998888 |
Resistant |
| ENSG00000233695.1 |
Nilotinib |
Stomach adenocarcinoma |
0.002671272 |
Resistant |
| ENSG00000234456.3 |
Nilotinib |
Stomach adenocarcinoma |
0.04165387 |
Resistant |
| ENSG00000250786.1 |
Nilotinib |
Stomach adenocarcinoma |
0.046720145 |
Resistant |
| ENSG00000253392.2 |
Nilotinib |
Stomach adenocarcinoma |
0.003182751 |
Resistant |
| ENSG00000253931.1 |
Nilotinib |
Stomach adenocarcinoma |
0.029059406 |
Resistant |
| ENSG00000260671.1 |
Nilotinib |
Stomach adenocarcinoma |
0.040297997 |
Resistant |
| ENSG00000267654.1 |
Nilotinib |
Stomach adenocarcinoma |
0.018589506 |
Resistant |
| ENSG00000270117.1 |
Nilotinib |
Stomach adenocarcinoma |
0.023206794 |
Resistant |
| ENSG00000175967.3 |
Nilotinib |
Bladder urothelial carcinoma |
0.000836212 |
Sensitive |
| ENSG00000182310.8 |
Nilotinib |
Bladder urothelial carcinoma |
0.016995643 |
Sensitive |
| ENSG00000204934.6 |
Nilotinib |
Bladder urothelial carcinoma |
0.046513988 |
Sensitive |
| ENSG00000213971.3 |
Nilotinib |
Bladder urothelial carcinoma |
0.032721879 |
Sensitive |
| ENSG00000219665.4 |
Nilotinib |
Bladder urothelial carcinoma |
0.026534826 |
Sensitive |
| ENSG00000223598.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.030242524 |
Sensitive |
| ENSG00000224093.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.000668456 |
Sensitive |
| ENSG00000224733.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.017613365 |
Sensitive |
| ENSG00000224885.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.041413187 |
Sensitive |
| ENSG00000225030.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.026209501 |
Sensitive |
| ENSG00000225163.3 |
Nilotinib |
Bladder urothelial carcinoma |
0.04646783 |
Sensitive |
| ENSG00000225767.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.000200331 |
Sensitive |
| ENSG00000226047.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.019201694 |
Sensitive |
| ENSG00000226645.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.027034612 |
Sensitive |
| ENSG00000226751.2 |
Nilotinib |
Bladder urothelial carcinoma |
0.035179255 |
Sensitive |
| ENSG00000227071.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.029669718 |
Sensitive |
| ENSG00000227945.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.045827013 |
Sensitive |
| ENSG00000228237.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.00993063 |
Sensitive |
| ENSG00000228838.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.045568849 |
Sensitive |
| ENSG00000229444.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.012539261 |
Sensitive |
| ENSG00000229867.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.038964511 |
Sensitive |
| ENSG00000231201.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.008400125 |
Sensitive |
| ENSG00000231628.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.049570449 |
Sensitive |
| ENSG00000232117.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.0000551 |
Sensitive |
| ENSG00000232593.2 |
Nilotinib |
Bladder urothelial carcinoma |
0.025559425 |
Sensitive |
| ENSG00000232762.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.007832792 |
Sensitive |
| ENSG00000233723.3 |
Nilotinib |
Bladder urothelial carcinoma |
0.001728317 |
Sensitive |
| ENSG00000234393.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.003250625 |
Sensitive |
| ENSG00000234616.4 |
Nilotinib |
Bladder urothelial carcinoma |
0.037973314 |
Sensitive |
| ENSG00000234773.2 |
Nilotinib |
Bladder urothelial carcinoma |
0.016893561 |
Sensitive |
| ENSG00000235740.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.031254224 |
Sensitive |
| ENSG00000236498.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.016026898 |
Sensitive |
| ENSG00000236869.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.004836693 |
Sensitive |
| ENSG00000237807.3 |
Nilotinib |
Bladder urothelial carcinoma |
0.017098612 |
Sensitive |
| ENSG00000238068.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.02099741 |
Sensitive |
| ENSG00000238287.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.027674405 |
Sensitive |
| ENSG00000239335.4 |
Nilotinib |
Bladder urothelial carcinoma |
0.025426461 |
Sensitive |
| ENSG00000241479.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.007996161 |
Sensitive |
| ENSG00000242516.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.029603343 |
Sensitive |
| ENSG00000247516.3 |
Nilotinib |
Bladder urothelial carcinoma |
0.012993469 |
Sensitive |
| ENSG00000248664.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.036782936 |
Sensitive |
| ENSG00000248773.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.020753557 |
Sensitive |
| ENSG00000249592.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.033100558 |
Sensitive |
| ENSG00000253121.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.046613245 |
Sensitive |
| ENSG00000254027.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.024182665 |
Sensitive |
| ENSG00000254204.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.025393862 |
Sensitive |
| ENSG00000254409.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.005757702 |
Sensitive |
| ENSG00000254560.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.011087779 |
Sensitive |
| ENSG00000254606.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.009650948 |
Sensitive |
| ENSG00000254791.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.011671809 |
Sensitive |
| ENSG00000255322.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.009369756 |
Sensitive |
| ENSG00000255843.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.032002799 |
Sensitive |
| ENSG00000256448.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.005620124 |
Sensitive |
| ENSG00000256588.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.008812548 |
Sensitive |
| ENSG00000258620.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.012664736 |
Sensitive |
| ENSG00000258825.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.007060926 |
Sensitive |
| ENSG00000259070.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.029637241 |
Sensitive |
| ENSG00000259583.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.031689899 |
Sensitive |
| ENSG00000260276.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.00084261 |
Sensitive |
| ENSG00000260368.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.026557062 |
Sensitive |
| ENSG00000260735.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.042183186 |
Sensitive |
| ENSG00000261490.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.004654055 |
Sensitive |
| ENSG00000261783.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.042551631 |
Sensitive |
| ENSG00000262074.3 |
Nilotinib |
Bladder urothelial carcinoma |
0.039012545 |
Sensitive |
| ENSG00000262147.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.020303052 |
Sensitive |
| ENSG00000262202.3 |
Nilotinib |
Bladder urothelial carcinoma |
0.024414118 |
Sensitive |
| ENSG00000262372.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.04432453 |
Sensitive |
| ENSG00000263069.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.046974164 |
Sensitive |
| ENSG00000263393.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.0025522 |
Sensitive |
| ENSG00000263466.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.003578318 |
Sensitive |
| ENSG00000267096.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.019235106 |
Sensitive |
| ENSG00000268015.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.046021607 |
Sensitive |
| ENSG00000268970.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.043901613 |
Sensitive |
| ENSG00000269102.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.034142288 |
Sensitive |
| ENSG00000269148.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.024541039 |
Sensitive |
| ENSG00000269487.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.036579521 |
Sensitive |
| ENSG00000269653.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.02211667 |
Sensitive |
| ENSG00000270012.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.038239238 |
Sensitive |
| ENSG00000270062.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.033263978 |
Sensitive |
| ENSG00000270189.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.033015907 |
Sensitive |
| ENSG00000271778.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.013800643 |
Sensitive |
| ENSG00000272198.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.025413475 |
Sensitive |
| ENSG00000272368.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.004472543 |
Sensitive |
| ENSG00000273133.1 |
Nilotinib |
Bladder urothelial carcinoma |
0.008772037 |
Sensitive |
| ENSG00000186369.5 |
Nilotinib |
Breast invasive carcinoma |
0.040547931 |
Sensitive |
| ENSG00000213863.2 |
Nilotinib |
Breast invasive carcinoma |
0.027769674 |
Sensitive |
| ENSG00000223478.1 |
Nilotinib |
Breast invasive carcinoma |
0.001857523 |
Sensitive |
| ENSG00000225778.1 |
Nilotinib |
Breast invasive carcinoma |
0.030748235 |
Sensitive |
| ENSG00000225793.2 |
Nilotinib |
Breast invasive carcinoma |
0.031282128 |
Sensitive |
| ENSG00000225836.1 |
Nilotinib |
Breast invasive carcinoma |
0.018326588 |
Sensitive |
| ENSG00000226419.2 |
Nilotinib |
Breast invasive carcinoma |
0.032651834 |
Sensitive |
| ENSG00000228509.1 |
Nilotinib |
Breast invasive carcinoma |
0.014516464 |
Sensitive |
| ENSG00000228649.4 |
Nilotinib |
Breast invasive carcinoma |
0.028556444 |
Sensitive |
| ENSG00000230082.1 |
Nilotinib |
Breast invasive carcinoma |
0.02345692 |
Sensitive |
| ENSG00000230698.1 |
Nilotinib |
Breast invasive carcinoma |
0.039389585 |
Sensitive |
| ENSG00000231563.1 |
Nilotinib |
Breast invasive carcinoma |
0.019253437 |
Sensitive |
| ENSG00000232093.1 |
Nilotinib |
Breast invasive carcinoma |
0.035290547 |
Sensitive |
| ENSG00000233800.2 |
Nilotinib |
Breast invasive carcinoma |
0.01173382 |
Sensitive |
| ENSG00000235237.1 |
Nilotinib |
Breast invasive carcinoma |
0.021033332 |
Sensitive |
| ENSG00000237485.1 |
Nilotinib |
Breast invasive carcinoma |
0.027617007 |
Sensitive |
| ENSG00000237523.1 |
Nilotinib |
Breast invasive carcinoma |
0.003111114 |
Sensitive |
| ENSG00000237594.2 |
Nilotinib |
Breast invasive carcinoma |
0.029903577 |
Sensitive |
| ENSG00000238005.2 |
Nilotinib |
Breast invasive carcinoma |
0.037681501 |
Sensitive |
| ENSG00000241764.3 |
Nilotinib |
Breast invasive carcinoma |
0.049694686 |
Sensitive |
| ENSG00000243926.1 |
Nilotinib |
Breast invasive carcinoma |
0.011512942 |
Sensitive |
| ENSG00000247809.3 |
Nilotinib |
Breast invasive carcinoma |
0.000985723 |
Sensitive |
| ENSG00000248719.1 |
Nilotinib |
Breast invasive carcinoma |
0.039759379 |
Sensitive |
| ENSG00000248968.1 |
Nilotinib |
Breast invasive carcinoma |
0.034756565 |
Sensitive |
| ENSG00000251292.1 |
Nilotinib |
Breast invasive carcinoma |
0.047728582 |
Sensitive |
| ENSG00000251307.1 |
Nilotinib |
Breast invasive carcinoma |
0.013214088 |
Sensitive |
| ENSG00000253549.1 |
Nilotinib |
Breast invasive carcinoma |
0.048429121 |
Sensitive |
| ENSG00000254109.1 |
Nilotinib |
Breast invasive carcinoma |
0.005894306 |
Sensitive |
| ENSG00000254205.1 |
Nilotinib |
Breast invasive carcinoma |
0.034032212 |
Sensitive |
| ENSG00000254485.1 |
Nilotinib |
Breast invasive carcinoma |
0.016531976 |
Sensitive |
| ENSG00000258137.1 |
Nilotinib |
Breast invasive carcinoma |
0.030247721 |
Sensitive |
| ENSG00000259038.1 |
Nilotinib |
Breast invasive carcinoma |
0.001775308 |
Sensitive |
| ENSG00000259275.1 |
Nilotinib |
Breast invasive carcinoma |
0.025744329 |
Sensitive |
| ENSG00000260448.1 |
Nilotinib |
Breast invasive carcinoma |
0.034564476 |
Sensitive |
| ENSG00000260507.1 |
Nilotinib |
Breast invasive carcinoma |
0.029386139 |
Sensitive |
| ENSG00000260661.1 |
Nilotinib |
Breast invasive carcinoma |
0.046966414 |
Sensitive |
| ENSG00000260790.1 |
Nilotinib |
Breast invasive carcinoma |
0.02893346 |
Sensitive |
| ENSG00000261105.1 |
Nilotinib |
Breast invasive carcinoma |
0.038357397 |
Sensitive |
| ENSG00000261471.1 |
Nilotinib |
Breast invasive carcinoma |
0.016796483 |
Sensitive |
| ENSG00000262296.1 |
Nilotinib |
Breast invasive carcinoma |
0.02279364 |
Sensitive |
| ENSG00000266446.1 |
Nilotinib |
Breast invasive carcinoma |
0.022322407 |
Sensitive |
| ENSG00000267024.1 |
Nilotinib |
Breast invasive carcinoma |
0.043828247 |
Sensitive |
| ENSG00000271133.1 |
Nilotinib |
Breast invasive carcinoma |
0.030173211 |
Sensitive |
| ENSG00000272198.1 |
Nilotinib |
Breast invasive carcinoma |
0.03886082 |
Sensitive |
| ENSG00000272520.1 |
Nilotinib |
Breast invasive carcinoma |
0.016965462 |
Sensitive |
| ENSG00000273061.1 |
Nilotinib |
Breast invasive carcinoma |
0.012286223 |
Sensitive |
| ENSG00000273077.1 |
Nilotinib |
Breast invasive carcinoma |
0.027380035 |
Sensitive |
| ENSG00000223784.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005987771 |
Sensitive |
| ENSG00000225744.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011768757 |
Sensitive |
| ENSG00000235725.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034945524 |
Sensitive |
| ENSG00000237807.3 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009268787 |
Sensitive |
| ENSG00000244300.2 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00856865 |
Sensitive |
| ENSG00000259103.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030345202 |
Sensitive |
| ENSG00000260025.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014606901 |
Sensitive |
| ENSG00000260693.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034924478 |
Sensitive |
| ENSG00000267374.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002502123 |
Sensitive |
| ENSG00000267922.1 |
Nilotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047105348 |
Sensitive |
| ENSG00000185186.4 |
Nilotinib |
Esophageal cancer |
0.048640587 |
Sensitive |
| ENSG00000203808.6 |
Nilotinib |
Esophageal cancer |
0.04360992 |
Sensitive |
| ENSG00000204815.4 |
Nilotinib |
Esophageal cancer |
0.00567404 |
Sensitive |
| ENSG00000214049.6 |
Nilotinib |
Esophageal cancer |
0.046557411 |
Sensitive |
| ENSG00000214870.4 |
Nilotinib |
Esophageal cancer |
0.028592079 |
Sensitive |
| ENSG00000223404.3 |
Nilotinib |
Esophageal cancer |
0.025941535 |
Sensitive |
| ENSG00000223461.1 |
Nilotinib |
Esophageal cancer |
0.004434615 |
Sensitive |
| ENSG00000223478.1 |
Nilotinib |
Esophageal cancer |
0.002057047 |
Sensitive |
| ENSG00000223546.2 |
Nilotinib |
Esophageal cancer |
0.015139184 |
Sensitive |
| ENSG00000224043.3 |
Nilotinib |
Esophageal cancer |
0.003280565 |
Sensitive |
| ENSG00000224884.1 |
Nilotinib |
Esophageal cancer |
0.037047037 |
Sensitive |
| ENSG00000225439.2 |
Nilotinib |
Esophageal cancer |
0.033378205 |
Sensitive |
| ENSG00000225684.3 |
Nilotinib |
Esophageal cancer |
0.048735277 |
Sensitive |
| ENSG00000225725.4 |
Nilotinib |
Esophageal cancer |
0.027369755 |
Sensitive |
| ENSG00000226332.2 |
Nilotinib |
Esophageal cancer |
0.00711212 |
Sensitive |
| ENSG00000226756.1 |
Nilotinib |
Esophageal cancer |
0.007385653 |
Sensitive |
| ENSG00000227431.1 |
Nilotinib |
Esophageal cancer |
0.004305406 |
Sensitive |
| ENSG00000227512.1 |
Nilotinib |
Esophageal cancer |
0.008810554 |
Sensitive |
| ENSG00000227589.1 |
Nilotinib |
Esophageal cancer |
0.022910656 |
Sensitive |
| ENSG00000227954.2 |
Nilotinib |
Esophageal cancer |
0.001960666 |
Sensitive |
| ENSG00000229153.1 |
Nilotinib |
Esophageal cancer |
0.045947544 |
Sensitive |
| ENSG00000229582.2 |
Nilotinib |
Esophageal cancer |
0.020324826 |
Sensitive |
| ENSG00000229660.1 |
Nilotinib |
Esophageal cancer |
0.008604663 |
Sensitive |
| ENSG00000230550.1 |
Nilotinib |
Esophageal cancer |
0.002910104 |
Sensitive |
| ENSG00000231056.1 |
Nilotinib |
Esophageal cancer |
0.00787151 |
Sensitive |
| ENSG00000231187.2 |
Nilotinib |
Esophageal cancer |
0.002639358 |
Sensitive |
| ENSG00000231453.1 |
Nilotinib |
Esophageal cancer |
0.037782806 |
Sensitive |
| ENSG00000232533.1 |
Nilotinib |
Esophageal cancer |
0.0437554 |
Sensitive |
| ENSG00000232545.1 |
Nilotinib |
Esophageal cancer |
0.037243479 |
Sensitive |
| ENSG00000232907.3 |
Nilotinib |
Esophageal cancer |
0.031788665 |
Sensitive |
| ENSG00000233847.1 |
Nilotinib |
Esophageal cancer |
0.030164739 |
Sensitive |
| ENSG00000234141.1 |
Nilotinib |
Esophageal cancer |
0.048073609 |
Sensitive |
| ENSG00000234913.1 |
Nilotinib |
Esophageal cancer |
0.010045533 |
Sensitive |
| ENSG00000235079.1 |
Nilotinib |
Esophageal cancer |
0.005504224 |
Sensitive |
| ENSG00000235387.1 |
Nilotinib |
Esophageal cancer |
0.013974201 |
Sensitive |
| ENSG00000235586.1 |
Nilotinib |
Esophageal cancer |
0.005680496 |
Sensitive |
| ENSG00000235643.1 |
Nilotinib |
Esophageal cancer |
0.033722603 |
Sensitive |
| ENSG00000236078.1 |
Nilotinib |
Esophageal cancer |
0.032712153 |
Sensitive |
| ENSG00000236200.1 |
Nilotinib |
Esophageal cancer |
0.028276162 |
Sensitive |
| ENSG00000236449.1 |
Nilotinib |
Esophageal cancer |
0.041294102 |
Sensitive |
| ENSG00000236540.3 |
Nilotinib |
Esophageal cancer |
0.00941453 |
Sensitive |
| ENSG00000236935.1 |
Nilotinib |
Esophageal cancer |
0.001049294 |
Sensitive |
| ENSG00000236947.1 |
Nilotinib |
Esophageal cancer |
0.001715992 |
Sensitive |
| ENSG00000236983.1 |
Nilotinib |
Esophageal cancer |
0.004356544 |
Sensitive |
| ENSG00000237689.1 |
Nilotinib |
Esophageal cancer |
0.016469424 |
Sensitive |
| ENSG00000237737.1 |
Nilotinib |
Esophageal cancer |
0.023416691 |
Sensitive |
| ENSG00000237738.1 |
Nilotinib |
Esophageal cancer |
0.012291546 |
Sensitive |
| ENSG00000239407.1 |
Nilotinib |
Esophageal cancer |
0.018244071 |
Sensitive |
| ENSG00000239498.1 |
Nilotinib |
Esophageal cancer |
0.026194743 |
Sensitive |
| ENSG00000240207.2 |
Nilotinib |
Esophageal cancer |
0.023397655 |
Sensitive |
| ENSG00000240476.1 |
Nilotinib |
Esophageal cancer |
0.006247261 |
Sensitive |
| ENSG00000240990.5 |
Nilotinib |
Esophageal cancer |
0.025084611 |
Sensitive |
| ENSG00000241316.2 |
Nilotinib |
Esophageal cancer |
0.004369374 |
Sensitive |
| ENSG00000243766.3 |
Nilotinib |
Esophageal cancer |
0.010932685 |
Sensitive |
| ENSG00000245105.1 |
Nilotinib |
Esophageal cancer |
0.028475858 |
Sensitive |
| ENSG00000245869.2 |
Nilotinib |
Esophageal cancer |
0.015502887 |
Sensitive |
| ENSG00000248846.2 |
Nilotinib |
Esophageal cancer |
0.04676093 |
Sensitive |
| ENSG00000250608.1 |
Nilotinib |
Esophageal cancer |
0.022656417 |
Sensitive |
| ENSG00000253390.1 |
Nilotinib |
Esophageal cancer |
0.033926768 |
Sensitive |
| ENSG00000253552.3 |
Nilotinib |
Esophageal cancer |
0.004402614 |
Sensitive |
| ENSG00000253603.1 |
Nilotinib |
Esophageal cancer |
0.028187691 |
Sensitive |
| ENSG00000253669.3 |
Nilotinib |
Esophageal cancer |
0.040905278 |
Sensitive |
| ENSG00000253986.1 |
Nilotinib |
Esophageal cancer |
0.001372629 |
Sensitive |
| ENSG00000255176.1 |
Nilotinib |
Esophageal cancer |
0.021594078 |
Sensitive |
| ENSG00000255471.1 |
Nilotinib |
Esophageal cancer |
0.049073439 |
Sensitive |
| ENSG00000255521.1 |
Nilotinib |
Esophageal cancer |
0.026708201 |
Sensitive |
| ENSG00000255968.1 |
Nilotinib |
Esophageal cancer |
0.013251083 |
Sensitive |
| ENSG00000256943.1 |
Nilotinib |
Esophageal cancer |
0.026364368 |
Sensitive |
| ENSG00000257711.1 |
Nilotinib |
Esophageal cancer |
0.016126793 |
Sensitive |
| ENSG00000258442.1 |
Nilotinib |
Esophageal cancer |
0.041045859 |
Sensitive |
| ENSG00000258520.1 |
Nilotinib |
Esophageal cancer |
0.046024796 |
Sensitive |
| ENSG00000259219.1 |
Nilotinib |
Esophageal cancer |
0.002193824 |
Sensitive |
| ENSG00000259230.1 |
Nilotinib |
Esophageal cancer |
0.017846265 |
Sensitive |
| ENSG00000259364.1 |
Nilotinib |
Esophageal cancer |
0.014655795 |
Sensitive |
| ENSG00000259456.2 |
Nilotinib |
Esophageal cancer |
0.003803063 |
Sensitive |
| ENSG00000259920.1 |
Nilotinib |
Esophageal cancer |
0.007034381 |
Sensitive |
| ENSG00000260194.1 |
Nilotinib |
Esophageal cancer |
0.045661332 |
Sensitive |
| ENSG00000260608.1 |
Nilotinib |
Esophageal cancer |
0.030543518 |
Sensitive |
| ENSG00000260833.2 |
Nilotinib |
Esophageal cancer |
0.00079296 |
Sensitive |
| ENSG00000260938.1 |
Nilotinib |
Esophageal cancer |
0.030347677 |
Sensitive |
| ENSG00000261040.2 |
Nilotinib |
Esophageal cancer |
0.032570337 |
Sensitive |
| ENSG00000261207.1 |
Nilotinib |
Esophageal cancer |
0.001430378 |
Sensitive |
| ENSG00000261341.1 |
Nilotinib |
Esophageal cancer |
0.010894436 |
Sensitive |
| ENSG00000262833.1 |
Nilotinib |
Esophageal cancer |
0.013871378 |
Sensitive |
| ENSG00000264339.1 |
Nilotinib |
Esophageal cancer |
0.047353492 |
Sensitive |
| ENSG00000265218.1 |
Nilotinib |
Esophageal cancer |
0.03973927 |
Sensitive |
| ENSG00000266371.1 |
Nilotinib |
Esophageal cancer |
0.001317905 |
Sensitive |
| ENSG00000266644.1 |
Nilotinib |
Esophageal cancer |
0.005257352 |
Sensitive |
| ENSG00000266709.1 |
Nilotinib |
Esophageal cancer |
0.043444375 |
Sensitive |
| ENSG00000266805.1 |
Nilotinib |
Esophageal cancer |
0.044645855 |
Sensitive |
| ENSG00000267069.1 |
Nilotinib |
Esophageal cancer |
0.001072942 |
Sensitive |
| ENSG00000267308.1 |
Nilotinib |
Esophageal cancer |
0.012188878 |
Sensitive |
| ENSG00000267476.1 |
Nilotinib |
Esophageal cancer |
0.028920372 |
Sensitive |
| ENSG00000267519.2 |
Nilotinib |
Esophageal cancer |
0.015951651 |
Sensitive |
| ENSG00000267577.1 |
Nilotinib |
Esophageal cancer |
0.039945062 |
Sensitive |
| ENSG00000267637.1 |
Nilotinib |
Esophageal cancer |
0.021728337 |
Sensitive |
| ENSG00000267764.1 |
Nilotinib |
Esophageal cancer |
0.03307929 |
Sensitive |
| ENSG00000267778.1 |
Nilotinib |
Esophageal cancer |
0.005849247 |
Sensitive |
| ENSG00000267874.1 |
Nilotinib |
Esophageal cancer |
0.031349839 |
Sensitive |
| ENSG00000268001.1 |
Nilotinib |
Esophageal cancer |
0.01510252 |
Sensitive |
| ENSG00000268340.1 |
Nilotinib |
Esophageal cancer |
0.015116309 |
Sensitive |
| ENSG00000270265.1 |
Nilotinib |
Esophageal cancer |
0.045634666 |
Sensitive |
| ENSG00000270681.1 |
Nilotinib |
Esophageal cancer |
0.046710059 |
Sensitive |
| ENSG00000271590.1 |
Nilotinib |
Esophageal cancer |
0.004143539 |
Sensitive |
| ENSG00000272103.1 |
Nilotinib |
Esophageal cancer |
0.03086636 |
Sensitive |
| ENSG00000272129.1 |
Nilotinib |
Esophageal cancer |
0.024385757 |
Sensitive |
| ENSG00000272198.1 |
Nilotinib |
Esophageal cancer |
0.044332647 |
Sensitive |
| ENSG00000272361.1 |
Nilotinib |
Esophageal cancer |
0.039784782 |
Sensitive |
| ENSG00000272372.1 |
Nilotinib |
Esophageal cancer |
0.036255832 |
Sensitive |
| ENSG00000272430.1 |
Nilotinib |
Esophageal cancer |
0.029818309 |
Sensitive |
| ENSG00000272574.1 |
Nilotinib |
Esophageal cancer |
0.04936562 |
Sensitive |
| ENSG00000272914.1 |
Nilotinib |
Esophageal cancer |
0.004297152 |
Sensitive |
| ENSG00000272977.1 |
Nilotinib |
Esophageal cancer |
0.01655136 |
Sensitive |
| ENSG00000273032.1 |
Nilotinib |
Esophageal cancer |
0.015900194 |
Sensitive |
| ENSG00000273038.1 |
Nilotinib |
Esophageal cancer |
0.010636137 |
Sensitive |
| ENSG00000273164.1 |
Nilotinib |
Esophageal cancer |
0.036786595 |
Sensitive |
| ENSG00000273186.1 |
Nilotinib |
Esophageal cancer |
0.005056717 |
Sensitive |
| ENSG00000223576.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.04143566 |
Sensitive |
| ENSG00000223598.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.003056896 |
Sensitive |
| ENSG00000224899.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.021736325 |
Sensitive |
| ENSG00000225833.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.029728499 |
Sensitive |
| ENSG00000227039.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.041336048 |
Sensitive |
| ENSG00000233237.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.031966594 |
Sensitive |
| ENSG00000235904.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.031937585 |
Sensitive |
| ENSG00000236438.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.036284048 |
Sensitive |
| ENSG00000236833.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.040635236 |
Sensitive |
| ENSG00000237689.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.049927864 |
Sensitive |
| ENSG00000245311.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.049485968 |
Sensitive |
| ENSG00000245614.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.033510785 |
Sensitive |
| ENSG00000246363.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.024178697 |
Sensitive |
| ENSG00000247809.3 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.01761645 |
Sensitive |
| ENSG00000248092.3 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.014103392 |
Sensitive |
| ENSG00000248544.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.011903785 |
Sensitive |
| ENSG00000249096.2 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.008901053 |
Sensitive |
| ENSG00000249304.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.031797792 |
Sensitive |
| ENSG00000253404.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.003321735 |
Sensitive |
| ENSG00000258175.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.041354085 |
Sensitive |
| ENSG00000259163.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.028824507 |
Sensitive |
| ENSG00000259450.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.045985563 |
Sensitive |
| ENSG00000259453.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.005894187 |
Sensitive |
| ENSG00000260351.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.035604599 |
Sensitive |
| ENSG00000260831.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.010160903 |
Sensitive |
| ENSG00000261544.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.026476405 |
Sensitive |
| ENSG00000262362.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.031373215 |
Sensitive |
| ENSG00000263443.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.030421649 |
Sensitive |
| ENSG00000266283.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.010437699 |
Sensitive |
| ENSG00000267299.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.016848251 |
Sensitive |
| ENSG00000267798.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.009551513 |
Sensitive |
| ENSG00000268289.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.011024289 |
Sensitive |
| ENSG00000271109.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.013306639 |
Sensitive |
| ENSG00000271973.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.042933415 |
Sensitive |
| ENSG00000272079.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.030870116 |
Sensitive |
| ENSG00000272917.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.02021331 |
Sensitive |
| ENSG00000273113.1 |
Nilotinib |
Head and neck squamous cell carcinoma |
0.018058375 |
Sensitive |
| ENSG00000226686.3 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.036582434 |
Sensitive |
| ENSG00000234899.5 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.028910255 |
Sensitive |
| ENSG00000235843.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.029547255 |
Sensitive |
| ENSG00000236324.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.014409783 |
Sensitive |
| ENSG00000236537.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.000672222 |
Sensitive |
| ENSG00000250027.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.004578299 |
Sensitive |
| ENSG00000250295.2 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.02869132 |
Sensitive |
| ENSG00000256314.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.002052354 |
Sensitive |
| ENSG00000258188.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.042382421 |
Sensitive |
| ENSG00000259758.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.014590614 |
Sensitive |
| ENSG00000261544.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.038076699 |
Sensitive |
| ENSG00000264546.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.019436169 |
Sensitive |
| ENSG00000265801.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.042479065 |
Sensitive |
| ENSG00000266709.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.046429639 |
Sensitive |
| ENSG00000267637.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.039382067 |
Sensitive |
| ENSG00000272691.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.03508273 |
Sensitive |
| ENSG00000273017.1 |
Nilotinib |
Chronic Lymphocytic Leukemia |
0.0469336 |
Sensitive |
| ENSG00000224746.1 |
Nilotinib |
Brain lower grade glioma |
0.021133645 |
Sensitive |
| ENSG00000230001.1 |
Nilotinib |
Brain lower grade glioma |
0.023705846 |
Sensitive |
| ENSG00000231486.3 |
Nilotinib |
Brain lower grade glioma |
0.038717032 |
Sensitive |
| ENSG00000233086.3 |
Nilotinib |
Brain lower grade glioma |
0.047690227 |
Sensitive |
| ENSG00000233221.2 |
Nilotinib |
Brain lower grade glioma |
0.046725687 |
Sensitive |
| ENSG00000239674.2 |
Nilotinib |
Brain lower grade glioma |
0.044459262 |
Sensitive |
| ENSG00000239828.2 |
Nilotinib |
Brain lower grade glioma |
0.039978822 |
Sensitive |
| ENSG00000249375.3 |
Nilotinib |
Brain lower grade glioma |
0.021791138 |
Sensitive |
| ENSG00000253642.1 |
Nilotinib |
Brain lower grade glioma |
0.03932214 |
Sensitive |
| ENSG00000255509.2 |
Nilotinib |
Brain lower grade glioma |
0.045876368 |
Sensitive |
| ENSG00000260022.1 |
Nilotinib |
Brain lower grade glioma |
0.030551648 |
Sensitive |
| ENSG00000260077.1 |
Nilotinib |
Brain lower grade glioma |
0.034048472 |
Sensitive |
| ENSG00000261327.3 |
Nilotinib |
Brain lower grade glioma |
0.028462997 |
Sensitive |
| ENSG00000261888.1 |
Nilotinib |
Brain lower grade glioma |
0.035392437 |
Sensitive |
| ENSG00000264433.1 |
Nilotinib |
Brain lower grade glioma |
0.037594587 |
Sensitive |
| ENSG00000264514.1 |
Nilotinib |
Brain lower grade glioma |
0.032700363 |
Sensitive |
| ENSG00000269983.1 |
Nilotinib |
Brain lower grade glioma |
0.042578331 |
Sensitive |
| ENSG00000174680.5 |
Nilotinib |
Lung squamous cell carcinoma |
0.023468793 |
Sensitive |
| ENSG00000224078.8 |
Nilotinib |
Lung squamous cell carcinoma |
0.022089573 |
Sensitive |
| ENSG00000224761.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.045488391 |
Sensitive |
| ENSG00000225063.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.040827512 |
Sensitive |
| ENSG00000225210.5 |
Nilotinib |
Lung squamous cell carcinoma |
0.039067669 |
Sensitive |
| ENSG00000226609.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.029361645 |
Sensitive |
| ENSG00000227083.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.026942977 |
Sensitive |
| ENSG00000228294.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.034315452 |
Sensitive |
| ENSG00000229983.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.009626391 |
Sensitive |
| ENSG00000230499.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.022912892 |
Sensitive |
| ENSG00000230550.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.030548226 |
Sensitive |
| ENSG00000230597.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.007995952 |
Sensitive |
| ENSG00000230612.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.012136019 |
Sensitive |
| ENSG00000231329.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.021809607 |
Sensitive |
| ENSG00000231638.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.034476853 |
Sensitive |
| ENSG00000231709.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.019323113 |
Sensitive |
| ENSG00000231842.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.023918482 |
Sensitive |
| ENSG00000232117.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.028727824 |
Sensitive |
| ENSG00000233339.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.011170811 |
Sensitive |
| ENSG00000233593.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.018227566 |
Sensitive |
| ENSG00000234327.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.034775916 |
Sensitive |
| ENSG00000235070.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.030573914 |
Sensitive |
| ENSG00000236463.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.002055556 |
Sensitive |
| ENSG00000236536.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.046070976 |
Sensitive |
| ENSG00000236760.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.038447912 |
Sensitive |
| ENSG00000236924.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.033651118 |
Sensitive |
| ENSG00000237380.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.021169029 |
Sensitive |
| ENSG00000237819.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.009266616 |
Sensitive |
| ENSG00000238198.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.004888875 |
Sensitive |
| ENSG00000239552.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.020704257 |
Sensitive |
| ENSG00000240254.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.045187525 |
Sensitive |
| ENSG00000245248.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.009976314 |
Sensitive |
| ENSG00000248890.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.040416719 |
Sensitive |
| ENSG00000249451.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.047060322 |
Sensitive |
| ENSG00000250106.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.033421984 |
Sensitive |
| ENSG00000253390.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.032801789 |
Sensitive |
| ENSG00000253986.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.047302624 |
Sensitive |
| ENSG00000254530.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.035508515 |
Sensitive |
| ENSG00000254556.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.01528511 |
Sensitive |
| ENSG00000254936.3 |
Nilotinib |
Lung squamous cell carcinoma |
0.026905281 |
Sensitive |
| ENSG00000255310.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.015163544 |
Sensitive |
| ENSG00000255790.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.03917125 |
Sensitive |
| ENSG00000255968.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.0100614 |
Sensitive |
| ENSG00000257126.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.027956045 |
Sensitive |
| ENSG00000257151.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.034533547 |
Sensitive |
| ENSG00000257647.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.035007701 |
Sensitive |
| ENSG00000257681.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.005138117 |
Sensitive |
| ENSG00000258402.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.024837404 |
Sensitive |
| ENSG00000258410.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.02540884 |
Sensitive |
| ENSG00000258556.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.020782312 |
Sensitive |
| ENSG00000259067.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.027997728 |
Sensitive |
| ENSG00000259336.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.018344411 |
Sensitive |
| ENSG00000259596.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.047052082 |
Sensitive |
| ENSG00000259863.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.01623986 |
Sensitive |
| ENSG00000260093.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.042107112 |
Sensitive |
| ENSG00000260262.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.018632262 |
Sensitive |
| ENSG00000260597.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.019554306 |
Sensitive |
| ENSG00000260645.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.009608595 |
Sensitive |
| ENSG00000260664.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.040581113 |
Sensitive |
| ENSG00000261460.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.047330964 |
Sensitive |
| ENSG00000261697.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.030715937 |
Sensitive |
| ENSG00000264078.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.036019293 |
Sensitive |
| ENSG00000264673.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.042719722 |
Sensitive |
| ENSG00000264729.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.047973885 |
Sensitive |
| ENSG00000266935.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.004590349 |
Sensitive |
| ENSG00000267287.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.016890426 |
Sensitive |
| ENSG00000267373.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.004530568 |
Sensitive |
| ENSG00000267638.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.014261832 |
Sensitive |
| ENSG00000269694.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.032907227 |
Sensitive |
| ENSG00000269802.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.039878118 |
Sensitive |
| ENSG00000269918.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.018271897 |
Sensitive |
| ENSG00000270246.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.031277065 |
Sensitive |
| ENSG00000270522.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.025235422 |
Sensitive |
| ENSG00000270704.2 |
Nilotinib |
Lung squamous cell carcinoma |
0.010028429 |
Sensitive |
| ENSG00000271270.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.006739467 |
Sensitive |
| ENSG00000271590.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.013137099 |
Sensitive |
| ENSG00000271889.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.012331521 |
Sensitive |
| ENSG00000272094.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.021216928 |
Sensitive |
| ENSG00000272574.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.034243685 |
Sensitive |
| ENSG00000272609.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.002044022 |
Sensitive |
| ENSG00000272650.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.039211804 |
Sensitive |
| ENSG00000272846.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.025415349 |
Sensitive |
| ENSG00000272848.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.007119052 |
Sensitive |
| ENSG00000272872.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.005160449 |
Sensitive |
| ENSG00000272905.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.02623009 |
Sensitive |
| ENSG00000272971.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.014537791 |
Sensitive |
| ENSG00000272983.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.01299706 |
Sensitive |
| ENSG00000273019.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.040521705 |
Sensitive |
| ENSG00000273108.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.038662706 |
Sensitive |
| ENSG00000273133.1 |
Nilotinib |
Lung squamous cell carcinoma |
0.002752145 |
Sensitive |
| ENSG00000212552.2 |
Nilotinib |
Sarcoma |
0.044557923 |
Sensitive |
| ENSG00000225442.2 |
Nilotinib |
Sarcoma |
0.044768608 |
Sensitive |
| ENSG00000230102.3 |
Nilotinib |
Sarcoma |
0.046774543 |
Sensitive |
| ENSG00000232956.4 |
Nilotinib |
Sarcoma |
0.047605624 |
Sensitive |
| ENSG00000233101.6 |
Nilotinib |
Sarcoma |
0.044320649 |
Sensitive |
| ENSG00000236140.1 |
Nilotinib |
Sarcoma |
0.043536424 |
Sensitive |
| ENSG00000236426.3 |
Nilotinib |
Sarcoma |
0.020354742 |
Sensitive |
| ENSG00000238142.1 |
Nilotinib |
Sarcoma |
0.006013596 |
Sensitive |
| ENSG00000249258.2 |
Nilotinib |
Sarcoma |
0.005944563 |
Sensitive |
| ENSG00000255435.2 |
Nilotinib |
Sarcoma |
0.00209732 |
Sensitive |
| ENSG00000256712.1 |
Nilotinib |
Sarcoma |
0.025636213 |
Sensitive |
| ENSG00000257497.1 |
Nilotinib |
Sarcoma |
0.004777032 |
Sensitive |
| ENSG00000258658.1 |
Nilotinib |
Sarcoma |
0.040607466 |
Sensitive |
| ENSG00000260646.1 |
Nilotinib |
Sarcoma |
0.016885991 |
Sensitive |
| ENSG00000266126.1 |
Nilotinib |
Sarcoma |
0.038432086 |
Sensitive |
| ENSG00000266289.1 |
Nilotinib |
Sarcoma |
0.028188992 |
Sensitive |
| ENSG00000266942.1 |
Nilotinib |
Sarcoma |
0.03257401 |
Sensitive |
| ENSG00000267405.1 |
Nilotinib |
Sarcoma |
0.031760222 |
Sensitive |
| ENSG00000267505.1 |
Nilotinib |
Sarcoma |
0.012293255 |
Sensitive |
| ENSG00000270066.2 |
Nilotinib |
Sarcoma |
0.034385193 |
Sensitive |
| ENSG00000272977.1 |
Nilotinib |
Sarcoma |
0.034129385 |
Sensitive |
| ENSG00000182165.13 |
Nilotinib |
Skin cutaneous melanoma |
0.037991983 |
Sensitive |
| ENSG00000204706.10 |
Nilotinib |
Skin cutaneous melanoma |
0.001248098 |
Sensitive |
| ENSG00000204929.7 |
Nilotinib |
Skin cutaneous melanoma |
0.003716283 |
Sensitive |
| ENSG00000223685.1 |
Nilotinib |
Skin cutaneous melanoma |
0.030321543 |
Sensitive |
| ENSG00000224649.1 |
Nilotinib |
Skin cutaneous melanoma |
0.042386157 |
Sensitive |
| ENSG00000224846.1 |
Nilotinib |
Skin cutaneous melanoma |
0.016284892 |
Sensitive |
| ENSG00000225725.4 |
Nilotinib |
Skin cutaneous melanoma |
0.02590857 |
Sensitive |
| ENSG00000226445.1 |
Nilotinib |
Skin cutaneous melanoma |
0.030544327 |
Sensitive |
| ENSG00000226711.2 |
Nilotinib |
Skin cutaneous melanoma |
0.00572293 |
Sensitive |
| ENSG00000226851.1 |
Nilotinib |
Skin cutaneous melanoma |
0.025056507 |
Sensitive |
| ENSG00000226904.1 |
Nilotinib |
Skin cutaneous melanoma |
0.039469334 |
Sensitive |
| ENSG00000227456.3 |
Nilotinib |
Skin cutaneous melanoma |
0.005609318 |
Sensitive |
| ENSG00000227681.1 |
Nilotinib |
Skin cutaneous melanoma |
0.040685793 |
Sensitive |
| ENSG00000228412.2 |
Nilotinib |
Skin cutaneous melanoma |
0.044909278 |
Sensitive |
| ENSG00000228775.3 |
Nilotinib |
Skin cutaneous melanoma |
0.023328628 |
Sensitive |
| ENSG00000229291.1 |
Nilotinib |
Skin cutaneous melanoma |
0.039965852 |
Sensitive |
| ENSG00000229487.1 |
Nilotinib |
Skin cutaneous melanoma |
0.023132241 |
Sensitive |
| ENSG00000230058.1 |
Nilotinib |
Skin cutaneous melanoma |
0.022353382 |
Sensitive |
| ENSG00000230939.1 |
Nilotinib |
Skin cutaneous melanoma |
0.043856548 |
Sensitive |
| ENSG00000231252.1 |
Nilotinib |
Skin cutaneous melanoma |
0.041194594 |
Sensitive |
| ENSG00000231346.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024067141 |
Sensitive |
| ENSG00000232077.1 |
Nilotinib |
Skin cutaneous melanoma |
0.012720887 |
Sensitive |
| ENSG00000233085.1 |
Nilotinib |
Skin cutaneous melanoma |
0.026775434 |
Sensitive |
| ENSG00000234350.1 |
Nilotinib |
Skin cutaneous melanoma |
0.042179113 |
Sensitive |
| ENSG00000235495.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024745974 |
Sensitive |
| ENSG00000235497.1 |
Nilotinib |
Skin cutaneous melanoma |
0.032615646 |
Sensitive |
| ENSG00000235615.2 |
Nilotinib |
Skin cutaneous melanoma |
0.03870802 |
Sensitive |
| ENSG00000236078.1 |
Nilotinib |
Skin cutaneous melanoma |
0.04530226 |
Sensitive |
| ENSG00000236345.1 |
Nilotinib |
Skin cutaneous melanoma |
0.030610881 |
Sensitive |
| ENSG00000236432.3 |
Nilotinib |
Skin cutaneous melanoma |
0.02371603 |
Sensitive |
| ENSG00000236545.1 |
Nilotinib |
Skin cutaneous melanoma |
0.018569776 |
Sensitive |
| ENSG00000236780.1 |
Nilotinib |
Skin cutaneous melanoma |
0.029955815 |
Sensitive |
| ENSG00000237234.2 |
Nilotinib |
Skin cutaneous melanoma |
0.040229109 |
Sensitive |
| ENSG00000237463.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024068301 |
Sensitive |
| ENSG00000237513.1 |
Nilotinib |
Skin cutaneous melanoma |
0.039004853 |
Sensitive |
| ENSG00000237927.1 |
Nilotinib |
Skin cutaneous melanoma |
0.040455215 |
Sensitive |
| ENSG00000238291.1 |
Nilotinib |
Skin cutaneous melanoma |
0.046033283 |
Sensitive |
| ENSG00000243069.3 |
Nilotinib |
Skin cutaneous melanoma |
0.017823158 |
Sensitive |
| ENSG00000245552.2 |
Nilotinib |
Skin cutaneous melanoma |
0.002551709 |
Sensitive |
| ENSG00000248174.1 |
Nilotinib |
Skin cutaneous melanoma |
0.030220866 |
Sensitive |
| ENSG00000248587.2 |
Nilotinib |
Skin cutaneous melanoma |
0.023305662 |
Sensitive |
| ENSG00000250073.2 |
Nilotinib |
Skin cutaneous melanoma |
0.026561978 |
Sensitive |
| ENSG00000250075.1 |
Nilotinib |
Skin cutaneous melanoma |
0.041927029 |
Sensitive |
| ENSG00000250133.2 |
Nilotinib |
Skin cutaneous melanoma |
0.021013172 |
Sensitive |
| ENSG00000250891.1 |
Nilotinib |
Skin cutaneous melanoma |
0.043794935 |
Sensitive |
| ENSG00000251292.1 |
Nilotinib |
Skin cutaneous melanoma |
0.049982864 |
Sensitive |
| ENSG00000253112.1 |
Nilotinib |
Skin cutaneous melanoma |
0.038699287 |
Sensitive |
| ENSG00000253641.1 |
Nilotinib |
Skin cutaneous melanoma |
0.031356582 |
Sensitive |
| ENSG00000254427.1 |
Nilotinib |
Skin cutaneous melanoma |
0.048799691 |
Sensitive |
| ENSG00000254739.1 |
Nilotinib |
Skin cutaneous melanoma |
0.028120254 |
Sensitive |
| ENSG00000254854.1 |
Nilotinib |
Skin cutaneous melanoma |
0.047669867 |
Sensitive |
| ENSG00000254964.1 |
Nilotinib |
Skin cutaneous melanoma |
0.00796147 |
Sensitive |
| ENSG00000255580.1 |
Nilotinib |
Skin cutaneous melanoma |
0.04274961 |
Sensitive |
| ENSG00000260231.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024775778 |
Sensitive |
| ENSG00000260877.1 |
Nilotinib |
Skin cutaneous melanoma |
0.041083949 |
Sensitive |
| ENSG00000260896.1 |
Nilotinib |
Skin cutaneous melanoma |
0.049614665 |
Sensitive |
| ENSG00000260971.3 |
Nilotinib |
Skin cutaneous melanoma |
0.02534477 |
Sensitive |
| ENSG00000261373.1 |
Nilotinib |
Skin cutaneous melanoma |
0.030636535 |
Sensitive |
| ENSG00000261584.1 |
Nilotinib |
Skin cutaneous melanoma |
0.013009076 |
Sensitive |
| ENSG00000262668.1 |
Nilotinib |
Skin cutaneous melanoma |
0.036727561 |
Sensitive |
| ENSG00000263293.1 |
Nilotinib |
Skin cutaneous melanoma |
0.034292587 |
Sensitive |
| ENSG00000265943.1 |
Nilotinib |
Skin cutaneous melanoma |
0.007214077 |
Sensitive |
| ENSG00000266957.1 |
Nilotinib |
Skin cutaneous melanoma |
0.034510593 |
Sensitive |
| ENSG00000267247.1 |
Nilotinib |
Skin cutaneous melanoma |
0.049505797 |
Sensitive |
| ENSG00000267522.1 |
Nilotinib |
Skin cutaneous melanoma |
0.031784463 |
Sensitive |
| ENSG00000267586.2 |
Nilotinib |
Skin cutaneous melanoma |
0.008263466 |
Sensitive |
| ENSG00000267651.1 |
Nilotinib |
Skin cutaneous melanoma |
0.035042798 |
Sensitive |
| ENSG00000267711.1 |
Nilotinib |
Skin cutaneous melanoma |
0.028869862 |
Sensitive |
| ENSG00000270074.1 |
Nilotinib |
Skin cutaneous melanoma |
0.041549574 |
Sensitive |
| ENSG00000271401.1 |
Nilotinib |
Skin cutaneous melanoma |
0.007640925 |
Sensitive |
| ENSG00000271967.1 |
Nilotinib |
Skin cutaneous melanoma |
0.049343373 |
Sensitive |
| ENSG00000272076.1 |
Nilotinib |
Skin cutaneous melanoma |
0.043589733 |
Sensitive |
| ENSG00000272077.1 |
Nilotinib |
Skin cutaneous melanoma |
0.020311139 |
Sensitive |
| ENSG00000272505.1 |
Nilotinib |
Skin cutaneous melanoma |
0.011843779 |
Sensitive |
| ENSG00000272745.1 |
Nilotinib |
Skin cutaneous melanoma |
0.041967929 |
Sensitive |
| ENSG00000272966.1 |
Nilotinib |
Skin cutaneous melanoma |
0.015635769 |
Sensitive |
| ENSG00000272970.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024354094 |
Sensitive |
| ENSG00000273014.1 |
Nilotinib |
Skin cutaneous melanoma |
0.018780202 |
Sensitive |
| ENSG00000273081.1 |
Nilotinib |
Skin cutaneous melanoma |
0.024077096 |
Sensitive |
| ENSG00000273084.1 |
Nilotinib |
Skin cutaneous melanoma |
0.035279352 |
Sensitive |
| ENSG00000273366.1 |
Nilotinib |
Skin cutaneous melanoma |
0.019230981 |
Sensitive |
| ENSG00000273367.1 |
Nilotinib |
Skin cutaneous melanoma |
0.044335006 |
Sensitive |
| ENSG00000142396.6 |
Nilotinib |
Stomach adenocarcinoma |
0.04186032 |
Sensitive |
| ENSG00000175147.7 |
Nilotinib |
Stomach adenocarcinoma |
0.022540355 |
Sensitive |
| ENSG00000177788.5 |
Nilotinib |
Stomach adenocarcinoma |
0.027984622 |
Sensitive |
| ENSG00000182165.13 |
Nilotinib |
Stomach adenocarcinoma |
0.034567252 |
Sensitive |
| ENSG00000188206.5 |
Nilotinib |
Stomach adenocarcinoma |
0.027286054 |
Sensitive |
| ENSG00000213963.2 |
Nilotinib |
Stomach adenocarcinoma |
0.047512004 |
Sensitive |
| ENSG00000215908.5 |
Nilotinib |
Stomach adenocarcinoma |
0.036880233 |
Sensitive |
| ENSG00000223374.1 |
Nilotinib |
Stomach adenocarcinoma |
0.026682986 |
Sensitive |
| ENSG00000224138.1 |
Nilotinib |
Stomach adenocarcinoma |
0.015032052 |
Sensitive |
| ENSG00000224699.4 |
Nilotinib |
Stomach adenocarcinoma |
0.025209917 |
Sensitive |
| ENSG00000225177.1 |
Nilotinib |
Stomach adenocarcinoma |
0.049093017 |
Sensitive |
| ENSG00000226245.1 |
Nilotinib |
Stomach adenocarcinoma |
0.011474756 |
Sensitive |
| ENSG00000226824.2 |
Nilotinib |
Stomach adenocarcinoma |
0.002993021 |
Sensitive |
| ENSG00000226877.3 |
Nilotinib |
Stomach adenocarcinoma |
0.003160223 |
Sensitive |
| ENSG00000227071.1 |
Nilotinib |
Stomach adenocarcinoma |
0.000725519 |
Sensitive |
| ENSG00000227237.1 |
Nilotinib |
Stomach adenocarcinoma |
0.014366738 |
Sensitive |
| ENSG00000227285.1 |
Nilotinib |
Stomach adenocarcinoma |
0.0311628 |
Sensitive |
| ENSG00000227954.2 |
Nilotinib |
Stomach adenocarcinoma |
0.040905694 |
Sensitive |
| ENSG00000228115.1 |
Nilotinib |
Stomach adenocarcinoma |
0.021350575 |
Sensitive |
| ENSG00000228192.3 |
Nilotinib |
Stomach adenocarcinoma |
0.031248973 |
Sensitive |
| ENSG00000229127.1 |
Nilotinib |
Stomach adenocarcinoma |
0.000190746 |
Sensitive |
| ENSG00000229867.1 |
Nilotinib |
Stomach adenocarcinoma |
0.026730855 |
Sensitive |
| ENSG00000230124.2 |
Nilotinib |
Stomach adenocarcinoma |
0.045596184 |
Sensitive |
| ENSG00000231010.1 |
Nilotinib |
Stomach adenocarcinoma |
0.037886805 |
Sensitive |
| ENSG00000231530.1 |
Nilotinib |
Stomach adenocarcinoma |
0.048682558 |
Sensitive |
| ENSG00000231616.4 |
Nilotinib |
Stomach adenocarcinoma |
0.018632609 |
Sensitive |
| ENSG00000231731.3 |
Nilotinib |
Stomach adenocarcinoma |
0.01631932 |
Sensitive |
| ENSG00000232686.1 |
Nilotinib |
Stomach adenocarcinoma |
0.039785353 |
Sensitive |
| ENSG00000233654.1 |
Nilotinib |
Stomach adenocarcinoma |
0.030857394 |
Sensitive |
| ENSG00000234062.3 |
Nilotinib |
Stomach adenocarcinoma |
0.008510276 |
Sensitive |
| ENSG00000234281.1 |
Nilotinib |
Stomach adenocarcinoma |
0.045550999 |
Sensitive |
| ENSG00000235029.1 |
Nilotinib |
Stomach adenocarcinoma |
0.01269728 |
Sensitive |
| ENSG00000235477.2 |
Nilotinib |
Stomach adenocarcinoma |
0.000185997 |
Sensitive |
| ENSG00000236088.5 |
Nilotinib |
Stomach adenocarcinoma |
0.049371675 |
Sensitive |
| ENSG00000236199.1 |
Nilotinib |
Stomach adenocarcinoma |
0.028646611 |
Sensitive |
| ENSG00000236778.3 |
Nilotinib |
Stomach adenocarcinoma |
0.045973239 |
Sensitive |
| ENSG00000236824.1 |
Nilotinib |
Stomach adenocarcinoma |
0.01345535 |
Sensitive |
| ENSG00000236914.3 |
Nilotinib |
Stomach adenocarcinoma |
0.049469154 |
Sensitive |
| ENSG00000237126.4 |
Nilotinib |
Stomach adenocarcinoma |
0.033540182 |
Sensitive |
| ENSG00000237424.1 |
Nilotinib |
Stomach adenocarcinoma |
0.037654411 |
Sensitive |
| ENSG00000237489.2 |
Nilotinib |
Stomach adenocarcinoma |
0.005658764 |
Sensitive |
| ENSG00000237718.1 |
Nilotinib |
Stomach adenocarcinoma |
0.026025653 |
Sensitive |
| ENSG00000237877.2 |
Nilotinib |
Stomach adenocarcinoma |
0.047049562 |
Sensitive |
| ENSG00000237903.1 |
Nilotinib |
Stomach adenocarcinoma |
0.004660299 |
Sensitive |
| ENSG00000238009.2 |
Nilotinib |
Stomach adenocarcinoma |
0.005121803 |
Sensitive |
| ENSG00000238113.2 |
Nilotinib |
Stomach adenocarcinoma |
0.044256946 |
Sensitive |
| ENSG00000238198.1 |
Nilotinib |
Stomach adenocarcinoma |
0.005922607 |
Sensitive |
| ENSG00000239945.1 |
Nilotinib |
Stomach adenocarcinoma |
0.003620917 |
Sensitive |
| ENSG00000240291.1 |
Nilotinib |
Stomach adenocarcinoma |
0.020525553 |
Sensitive |
| ENSG00000242687.2 |
Nilotinib |
Stomach adenocarcinoma |
0.005871305 |
Sensitive |
| ENSG00000244459.2 |
Nilotinib |
Stomach adenocarcinoma |
0.004089532 |
Sensitive |
| ENSG00000245685.2 |
Nilotinib |
Stomach adenocarcinoma |
0.028174899 |
Sensitive |
| ENSG00000246089.3 |
Nilotinib |
Stomach adenocarcinoma |
0.041724854 |
Sensitive |
| ENSG00000246225.2 |
Nilotinib |
Stomach adenocarcinoma |
0.033017409 |
Sensitive |
| ENSG00000246898.1 |
Nilotinib |
Stomach adenocarcinoma |
0.016157068 |
Sensitive |
| ENSG00000248367.1 |
Nilotinib |
Stomach adenocarcinoma |
0.026346949 |
Sensitive |
| ENSG00000248663.2 |
Nilotinib |
Stomach adenocarcinoma |
0.042859551 |
Sensitive |
| ENSG00000249395.2 |
Nilotinib |
Stomach adenocarcinoma |
0.028614713 |
Sensitive |
| ENSG00000251666.1 |
Nilotinib |
Stomach adenocarcinoma |
0.006325288 |
Sensitive |
| ENSG00000253476.1 |
Nilotinib |
Stomach adenocarcinoma |
0.02049136 |
Sensitive |
| ENSG00000255857.1 |
Nilotinib |
Stomach adenocarcinoma |
0.016257862 |
Sensitive |
| ENSG00000256897.1 |
Nilotinib |
Stomach adenocarcinoma |
0.01785815 |
Sensitive |
| ENSG00000257681.1 |
Nilotinib |
Stomach adenocarcinoma |
0.006208579 |
Sensitive |
| ENSG00000258017.1 |
Nilotinib |
Stomach adenocarcinoma |
0.032950009 |
Sensitive |
| ENSG00000259215.1 |
Nilotinib |
Stomach adenocarcinoma |
0.046141288 |
Sensitive |
| ENSG00000259723.1 |
Nilotinib |
Stomach adenocarcinoma |
0.013400612 |
Sensitive |
| ENSG00000259959.1 |
Nilotinib |
Stomach adenocarcinoma |
0.032003224 |
Sensitive |
| ENSG00000260065.1 |
Nilotinib |
Stomach adenocarcinoma |
0.021479842 |
Sensitive |
| ENSG00000260349.1 |
Nilotinib |
Stomach adenocarcinoma |
0.04126981 |
Sensitive |
| ENSG00000260360.1 |
Nilotinib |
Stomach adenocarcinoma |
0.038001351 |
Sensitive |
| ENSG00000260361.1 |
Nilotinib |
Stomach adenocarcinoma |
0.038986602 |
Sensitive |
| ENSG00000260418.1 |
Nilotinib |
Stomach adenocarcinoma |
0.013438441 |
Sensitive |
| ENSG00000260517.1 |
Nilotinib |
Stomach adenocarcinoma |
0.007982815 |
Sensitive |
| ENSG00000260583.1 |
Nilotinib |
Stomach adenocarcinoma |
0.024063637 |
Sensitive |
| ENSG00000260766.1 |
Nilotinib |
Stomach adenocarcinoma |
0.012313711 |
Sensitive |
| ENSG00000260804.2 |
Nilotinib |
Stomach adenocarcinoma |
0.039320919 |
Sensitive |
| ENSG00000260920.1 |
Nilotinib |
Stomach adenocarcinoma |
0.037032522 |
Sensitive |
| ENSG00000260923.1 |
Nilotinib |
Stomach adenocarcinoma |
0.005060247 |
Sensitive |
| ENSG00000260988.1 |
Nilotinib |
Stomach adenocarcinoma |
0.040577306 |
Sensitive |
| ENSG00000261216.1 |
Nilotinib |
Stomach adenocarcinoma |
0.006711393 |
Sensitive |
| ENSG00000261428.1 |
Nilotinib |
Stomach adenocarcinoma |
0.006030422 |
Sensitive |
| ENSG00000261542.1 |
Nilotinib |
Stomach adenocarcinoma |
0.013041728 |
Sensitive |
| ENSG00000261744.1 |
Nilotinib |
Stomach adenocarcinoma |
0.048786153 |
Sensitive |
| ENSG00000264469.1 |
Nilotinib |
Stomach adenocarcinoma |
0.038264685 |
Sensitive |
| ENSG00000265242.1 |
Nilotinib |
Stomach adenocarcinoma |
0.008534457 |
Sensitive |
| ENSG00000267018.1 |
Nilotinib |
Stomach adenocarcinoma |
0.028473489 |
Sensitive |
| ENSG00000267871.1 |
Nilotinib |
Stomach adenocarcinoma |
0.022689693 |
Sensitive |
| ENSG00000268015.1 |
Nilotinib |
Stomach adenocarcinoma |
0.006708464 |
Sensitive |
| ENSG00000268189.2 |
Nilotinib |
Stomach adenocarcinoma |
0.037704161 |
Sensitive |
| ENSG00000268945.1 |
Nilotinib |
Stomach adenocarcinoma |
0.034575878 |
Sensitive |
| ENSG00000268970.1 |
Nilotinib |
Stomach adenocarcinoma |
0.043076569 |
Sensitive |
| ENSG00000269600.1 |
Nilotinib |
Stomach adenocarcinoma |
0.012569642 |
Sensitive |
| ENSG00000269956.1 |
Nilotinib |
Stomach adenocarcinoma |
0.049732768 |
Sensitive |
| ENSG00000270060.1 |
Nilotinib |
Stomach adenocarcinoma |
0.049509614 |
Sensitive |
| ENSG00000270084.1 |
Nilotinib |
Stomach adenocarcinoma |
0.000488761 |
Sensitive |
| ENSG00000270143.1 |
Nilotinib |
Stomach adenocarcinoma |
0.034473605 |
Sensitive |
| ENSG00000270189.1 |
Nilotinib |
Stomach adenocarcinoma |
0.007852502 |
Sensitive |
| ENSG00000270726.1 |
Nilotinib |
Stomach adenocarcinoma |
0.005516885 |
Sensitive |
| ENSG00000271789.1 |
Nilotinib |
Stomach adenocarcinoma |
0.029389215 |
Sensitive |
| ENSG00000271833.1 |
Nilotinib |
Stomach adenocarcinoma |
0.013547981 |
Sensitive |
| ENSG00000271983.1 |
Nilotinib |
Stomach adenocarcinoma |
0.010886434 |
Sensitive |
| ENSG00000272102.1 |
Nilotinib |
Stomach adenocarcinoma |
0.040675462 |
Sensitive |
| ENSG00000272452.1 |
Nilotinib |
Stomach adenocarcinoma |
0.016700512 |
Sensitive |
| ENSG00000272604.1 |
Nilotinib |
Stomach adenocarcinoma |
0.034941204 |
Sensitive |
| ENSG00000272659.1 |
Nilotinib |
Stomach adenocarcinoma |
0.012795974 |
Sensitive |
| ENSG00000272777.1 |
Nilotinib |
Stomach adenocarcinoma |
0.030124903 |
Sensitive |
| ENSG00000272902.1 |
Nilotinib |
Stomach adenocarcinoma |
0.031704532 |
Sensitive |
| ENSG00000272913.1 |
Nilotinib |
Stomach adenocarcinoma |
0.012083053 |
Sensitive |
| ENSG00000272931.1 |
Nilotinib |
Stomach adenocarcinoma |
0.02778946 |
Sensitive |
| ENSG00000272983.1 |
Nilotinib |
Stomach adenocarcinoma |
0.049963856 |
Sensitive |
| ENSG00000273014.1 |
Nilotinib |
Stomach adenocarcinoma |
0.014943159 |
Sensitive |
| ENSG00000273066.1 |
Nilotinib |
Stomach adenocarcinoma |
0.00693944 |
Sensitive |
| ENSG00000273131.1 |
Nilotinib |
Stomach adenocarcinoma |
0.028977651 |
Sensitive |
| ENSG00000273156.1 |
Nilotinib |
Stomach adenocarcinoma |
0.028389294 |
Sensitive |
| ENSG00000273240.1 |
Nilotinib |
Stomach adenocarcinoma |
0.035917558 |
Sensitive |
| ENSG00000273271.1 |
Nilotinib |
Stomach adenocarcinoma |
0.030320868 |
Sensitive |
| ENSG00000273447.1 |
Nilotinib |
Stomach adenocarcinoma |
0.026682475 |
Sensitive |
